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  Summary 
Summary  
This thesis deals with the regulatory inputs modulating the abundance of the protein 
Drebrin (Developmentally Regulated Brain Protein) in neurons, which is an actin-
binding protein capable of bundling actin filaments. Most excitatory synapses in the 
mammalian brain are formed on tiny protrusions, called dendritic spines that spread 
from the neuronal dendrite. It has been suggested that changes in dendritic spine 
morphology affect synaptic activity and plasticity, which are processes underlying 
memory formation, brain ageing, and some disorders, such as mental retardation. It is 
thought that Drebrin plays an important role in regulating dendritic spine morphology.  
Drebrin levels are known to recede with age and could be associated with cognitive 
decline. Moreover, some neurodegenerative conditions have been shown to be linked 
with a decrease in Drebrin abundance. A weakening in the expression of this protein 
in dendritic spines is associated with the loss of synaptic connections, a common 
feature of ageing and various neurological disorders such as Alzheimer's disease. This 
evidence was the underlying motivation for studying the localization and turnover of 
Drebrin. 
During the project reported in this thesis, I studied the effect of the site-specific S647 
phosphorylation of Drebrin and found that such post-translational modification 
regulates protein stability and turnover. For the project, it was necessary to establish 
several novel techniques in our laboratory, including state-of-the-art methods such as 
FUNCAT-PLA and Puro-PLA for the visualization of de novo synthesized proteins in 
situ. Furthermore, my results show that Drebrin translation occurs not only in somata 
but also locally in the dendrites and dendritic spines of neurons. The same observation 
is true for Drebrin transcripts, which are present both in the soma and dendrites of 
neurons. I obtained this result using high-resolution fluorescence in situ hybridization. 
These observations suggest that Drebrin could play an important role during synaptic 
plasticity.  My results allow the future investigation of the potential role of site-specific 
phosphorylation of Drebrin in spine morphology, in order to better understand the role 
of the protein in spines, as well as how its synthesis is controlled. Preliminary results 
in this direction are presented in this thesis. This PhD thesis represents a contribution 
to better understanding the regulation of Drebrin abundance. It also provides an 
experimental platform for additional investigation about the role of Drebrin in spine 
morphology, regarding its stability and its correlation with synaptic maintenance and 
function.
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Zusammenfassung 
Die vorliegende Arbeit erforscht die regulatorische Inputs, die die Expression von 
Drebrin (Developmentally Regulated Brain Protein) in Neuronen modulieren. Drebrin 
ist ein Protein das an Actin bindet und Actin-Filamente bündeln kann. Die meisten 
erregende Synapsen in Gehirnen von Säugetieren werden in kleinen 
Dendritenfortsätzen gebildet, die sogenannten Dendritendornen. Es ist postuliert 
worden, dass Änderungen in der Morphologie der Dendritendornen die synaptische 
Aktivität und Plastizität verändern können. Diese Prozesse spielen eine Rolle bei der 
Gedächtnisbildung und Alterung des Gehirns, sowie geistigen Störungen bzw. 
Behinderungen. Es wird angnommen, dass  Drebrin eine wichtige Rolle bei der 
Regulierung der Morphologie der Dendritendornen spielt. 
Es ist bekannt, dass die Drebrin-Präsenz im Alter zurückgeht – dies könnte kognitive 
Defizite erklären. Außerdem wurde gezeigt, dass einige neurodegenerative 
Krankheiten mit einer Reduzierung von Drebrin einhergehen. Eine Schwächung der 
Expression dieses Proteins in Dendritendornen ist mit einem Verlust an synaptischen 
Verbindungen gekoppelt, ein gemeinsames Merkmal von Alterung und neurologische 
Störungen, wie bei der Alzheimer Krankheit. Diese Befunde bildeten die Motivation 
und Grundlage für meine Erforschung der Produktion und Lokalisierung von Drebrin. 
Während meines Projektes, habe ich den Effekt der sequenzspezifische S647-
Phosphorylierung von Drebrin untersucht. Diese Arbeit zeigt, dass diese post-
translatorische Änderung die Stabilität und Produktion des Proteins reguliert. Es war 
für das Projekt notwendig neuartige experimentelle Verfahren in unserem Labor zu 
etablieren, wie z.B. FUNCAT-PLA und Puro-PLA, Methoden die den neusten Stand 
der Technik auf diese, Gebiet darstellen, letzteres für die Visualisierung von de novo 
synthetisierten Proteinen in situ. Außerdem zeigen meine Resultate, dass Drebrin-
Translation nicht nur im Zellkörper sondern auch lokal in den Dendritendornen 
stattfindet. Dasselbe gilt für Drebrin mRNA Transkripte, die sowohl im Zellkörper als 
auch in den Dendriten vorhanden sind. Diese Ergebnisse wurde durch den Einsatz 
von hochauflösender fluorizierender Hybridisierung in situ erreicht. Meine Resultate 
ermöglichen die zukünftige Erforschung der potentiellen Rolle der sequenz-spezifische 
Phosphorylierung von Drebrin für die Morphologie der Dendritendornen. Damit kann 
die Aktivität des Proteins in den Dendriten und die lokale Steuerung der Synthese dort 
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besser verstanden werden. Vorläufige Ergebnisse in diese Richtung werden in dieser 
Arbeit vorgestellt. 
Diese Dissertation bietet eine Grundlage für das Verständnis der Regulierung der 
Drebrin-Konzentration in Zellen. Die Arbeit liefert eine experimentelle Plattform für 
zusätzliche Studien der Rolle von Drebrin bei der Bestimmung der 
Dornenmorphologie, sowohl in Bezug auf Stabilität als auch hinsichtlich der Korrelation 
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Motivation 
This thesis addresses the role of the protein Drebrin (DBN) in neurons, and more 
specifically, the specific regulatory inputs that influence the expression and stability of 
DBN in dendritic spines. The effect of synaptic activity, oxidative stress, and post-
translational modification is studied through the adaptation to our needs of state of the 
art laboratory techniques, which let us image the spatio-temporal patterns of 
expression of DBN within neurons. This thesis represents a contribution towards the 
elucidation of the role of DBN both during the development and ageing of the human 
brain. 
DBN (developmentally-regulated brain protein) is an actin-binding protein present in 
cells of humans and other species. DBN was first identified in the chicken brain in 1985 
applying two-dimensional electrophoresis -- it was later characterized in mammals 
(Shirao and Obata, 1985). Its role as an interaction partner of the phosphatase and 
tensin homolog protein (PTEN) has been and is being studied in the Eickholt Lab 
(Charite Universitätsmedizin Berlin). Both DBN and PTEN are present in brain tissue. 
PTEN is a protein that can act as tumor suppressor. It can function as a protein and a 
lipid phosphatase. As a lipid phosphatase, PTEN directly antagonizes the PI3K 
pathway, responsible for fundamental processes in the cell, such as cell growth, cell-
cycle progression, metabolism, cell migration and protein synthesis. 
PTEN mutations have been identified in cancer patients, and in neurological disorders 
such as Cowden syndrome, Bannayan-Riley-Ruvalcaba, and in autism spectrum 
disorders (Pilarski et al., 2011).  
DBN was first identified as a developmentally regulated protein (hence the name) and 
is known to be important for neuronal development (Shirao and Obata, 1985). Using 
immunoelectron microscopy, it was shown shortly after its discovery that DBN is 
expressed in the dendrites of neurons from the cerebellar cortex of the chicken (Shirao 
et al., 1987). In 1989, DBN isoforms were first identified in rat brains by the Shirao 
group, and were first cloned and isolated from a human brain in 1993 (Toda M. et.al., 
1993).  
It was originally proposed that DBN affects neuronal morphogenesis because of its 
developmentally regulated expression and because of its actin-binding properties 
(Ishikawa et al., 1994). It has been shown to interact with other actin-binding proteins 
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and to modulate the morphology of dendritic spines in neurons – for example, it can 
induce the formation of filopodia-like structures in cells (Hayashi and Shirao, 1999; Jin 
et al., 2002; Mammoto et al., 1998; Sasaki et al., 1996). Furthermore, DBN-A, which is 
a brain-specific isoform, has been shown to alter synaptic activities of glutamatergic 
and GABAergic neurons in overexpression experiments (Ivanov et al., 2009a). DBN 
has also been linked to disease: for example, DBN levels are low in the brains of 
patients with Alzheimer’s disease (AD) and Down syndrome (Shim and Lubec, 2002). 
However, the specific mechanisms behind the potential role of DBN in degenerative 
brain conditions remains unknown. 
DBN is a phosphoprotein of which more than 13 phosphorylation sites have been 
identified. Post-translation modifications have been shown to regulate protein turnover 
in some cases. During the characterization of the PTEN-DBN protein-protein 
interaction (Kreis et al., 2013), it became clear that PTEN down regulation correlates 
with an increase in pDBN-S647 levels. Moreover, the interaction between DBN and 
PTEN was shown to partially occur in dendrites and to be synaptic activity dependent. 
However, the role of the S647 phosphorylation site remained unclear. Therefore, two 
main hypothesis were formulated regarding DBN function and control after those 
findings:  
• First, that the site-specific phosphorylation of DBN is important for the control of 
DBN turnover.  
• Second, that the spatial-temporal patterns of DBN could be relevant in the 
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In order to better understand how DBN is regulated and work towards proving or 
disproving these hypotheses, I pursued the following objectives during the realization 
of this thesis: 
1. Find regulatory inputs for DBN stability in the context of oxidative stress 
2. Study the effect of site-specific phosphorylation (S647/S601) on DBN stability 
and turnover. 
3. Study the spatial-temporal patterns of DBN expression in situ. 
4. Find regulatory inputs for DBN translation in the context of signaling cascades.  
The results of this research agenda are detailed in this thesis which is organized as 
follows:  
Chapter 1 is an introduction explaining the motivation for this project. It makes explicit 
the main hypothesis and objectives of this thesis. Moreover, it briefly describes what 
where the methodologies applied to produce the results.  Chapter 2 walks the reader 
through the results of the thesis – it is organized in three sections: Section 2.1 deals 
with the identification of regulatory inputs relevant to the abundance of DBN, and with 
the study of different cellular models for studying DBN turnover. Several important 
control experiments are discussed. They constitute the basis for further trials explained 
in the following sections, which include testing different DBN antibodies in western blot 
and in immunostaining. In order to explore the stability of DBN and the potential 
molecular mechanisms contributing to cognitive decline during aging and disease, I 
applied compounds known to induce oxidative stress, such as the herbicide paraquat 
and Amyloid beta peptide (Aβ). The results of the experiment are described in this 
section.  
Section 2.2 provides data showing the effect that site-specific phosphorylation has on 
DBN protein stability and turnover in overexpression models and in primary culture 
neurons. It describes state-of-the-art techniques for the visualization of de novo 
synthesis of DBN proteins in neurons, which I applied to study DBN turnover in primary 
neuronal cultures. Moreover, pulse-chase experiments in overexpression systems 
indicate that DBN degradation is inhibited when the proteasome itself is inhibited, 
suggesting a mechanism for degradation via the proteasome ubiquitin system (UPS). 
Together, these experiments indicate that C-terminal phosphorylation of DBN is an 
important regulatory input for the regulation of protein stability, and that DBN 
degradation might be at least partially controlled by the UPS.   
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Section 2.3 focuses on the regulation of DBN translation and the localization in neurons 
of DBN transcripts. Visualization in situ of both DBN transcripts and newly synthesized 
DBN, applying high-resolution fluorescence in situ hybridization and puromycilation-
PLA, respectively, confirm the presence of DBN transcripts and its translation both in 
soma and in dendrites. This observation, suggests and important role of the protein for 
synaptic plasticity, as discussed in this chapter. Finally and based on the previous 
finding that PTEN indirectly controls DBN abundance, I explore the potential regulation 
of the PI3K-mTOR pathway during DBN synthesis. I found that acute inhibition of 
mTOR reduces DBN translation.  
Chapter 3 discusses the main findings of this thesis. Chapter 4 ends with the 
conclusions and a discussion of future work. Finally, Chapter 5 contains a full 
description of the materials and methods that were used for obtaining the experimental 
data. 
As is evident from the description above, this thesis provides new insights about the 
molecular mechanisms and cellular processes controlling DBN turnover, and is a 
contribution towards understanding DBN’s potential role in the regulation of spine 
morphology. 
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1.1  Dendritic spines 
 
Neurons develop two types of functionally and morphologically different cytoplasmic 
processes: axons and dendrites. Axons are usually long and produce terminal 
branches. Their growth cones transform into presynaptic terminals which then form 
synapses with the dendrites of other neurons. Dendrites are not as long as axons but 
branch extensively, giving rise to dendritic trees with thousands of synapses (see 
Figure 1. for a schematic representation of morphological changes in neurons) (Luo L, 
2002). Most excitatory synapses extend directly from the dendrites. These are tiny 
postsynaptic protrusions called dendritic spines (Bourne and Harris, 2008). They are 
highly dynamic structures containing filamentous actin. This protein endows spines 
with dynamic properties -- it has been shown to be important for the morphogenesis 
and maintenance of dendritic spines.  
 
Figure 1| Schematic representation of morphological changes during neuronal development. 
Different stages in the life of a neuron (A-E) are visible. In E, the magnified inset represents 
dendritic spines, postsynaptic structures on dendrites. The long process growing on the bottom 
of the cell represents the axon, in this figure it is colored in red. Figure based on Luo L, 2002.  
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Different membrane morphologies can be observed during the development of spines. 
These include dendritic filopodia, which lack the postsynaptic compartment where 
scaffold proteins and synaptic receptors are found, and synaptic function. Dendritic 
filopodia have been proposed to function as precursor for dendritic spines. In addition 
to this, three further types of dendritic spines have been classified: the thin, stubby and 
mushroom shaped spines (see Figure 2 for a diagram) (Harris KM, 1992; Ziv NE & 
Smith SJ, 1996; Sekino Y et al., 2007). Thin spines have been strongly associated with 
plasticity -- it is believed that they play a role during the process of learning new 
information, whereas mushroom spines are thought to contribute to the formation of 
long-term memories and mediate strong synaptic currents (Morrison JH & Baxter MG, 
2012). Moreover, mushroom spines are commonly recognized as mature, being 
characterized by the presence of neurotransmitter receptors, scaffold proteins 
anchoring the receptors, intracellular signaling molecules and different actin-binding 
proteins. Mushroom spines play a crucial role in synaptic activity (Harris KM, 1992; 
Shim KS & Lubec G, 2002; Toni N et al., 2007; Sekino Y et al., 2007). The role of 
stubby spines remains unclear (Morrison JH & Baxter MG, 2012). The main players 
involved in shaping the structure of dendritic spines are the actin-binding proteins, 
which are able to polymerize or de-polymerize filamentous (F) actin in response to 
internal and external signals. In Section 2.3, further down, a detailed description on the 
actin-binding proteins in dendritic spines is provided.   
 
Figure 2| Schematic representation of the morphology of dendritic spines. Spine development 
starts with dendritic filopodia and continues with the formation of a head on top of them. It 
undergoes elongation, giving rise to different morphologies of dendritic spines, which correlate 
with synaptic activity and spine maturation.  Mature spines are characterized by a widening of 
their head, containing postsynaptic machinery (PSD and receptors) and a branched actin 
cytoskeleton (mushroom shaped dendritic spines: see the text for details). 
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1.2 Actin cytoskeleton in dendritic spines 
 
Actin is an evolutionary conserved protein. Three main actin isoforms are known in 
vertebrates, including the α-isoform expressed in different muscle cells, as well as the 
β- and γ- isoforms found together in almost all non-muscle cells (Dominguez R & 
Holmes KC, 2011). Actin in the cell is found as a monomer (globular or G-actin) and 
as a polymerized filament (filamentous or F-actin) (Sekino et al., 2007).  G-actin 
contains a binding site for ATP and, when bound to ATP, it self-assembles 
spontaneously through weak non-covalent interactions into F-actin. F-actin contains 
two ends: a “minus” or pointed end, which is rather stable, and a “plus” or barbed end, 
where polymerization occurs. F-actin turnover is controlled by several actin-binding 
proteins responsible for the stabilization or destabilization of actin filaments. They do 
this by promoting actin nucleation, elongation, capping, severing or depolymerization. 
This process is essential for the reorganization of the actin cytoskeleton in cells 
(Campellone KG & Welch MD, 2010).  Actin is one of the major components of the 
cytoskeleton, playing and important role in cell motility and shape dynamics, as well as 
contributing to other cellular functions such as cell division and intracellular protein 
trafficking.  
In the central nervous system (CNS), the actin cytoskeleton is essential for the 
establishment of neuron morphogenesis and maturation, as well as for a number of 
dynamic changes in morphology. Changes in the morphology of spines as well as 
changes in spine density along dendrites are processes that require actin cytoskeleton 
rearrangements. These changes have been linked to synaptic plasticity (Cingolani and 
Goda, 2008; Engert and Bonhoeffer, 1999) Actin filaments are the major cytoskeletal 
component in dendritic spines, but actin in spines is found both in its monomeric 
structure and in its filamentous conformation (Landis DM & Reese TS, 1983). It is well 
known that the actin cytoskeleton contributes to regulate dendritic spines 
morphogenesis, maintenance and motility, as well as to support postsynaptic receptor 
anchoring (Cingolani LA & Goda Y, 2008; Hotulainen P & Hoogenraad CC, 2010). 
Actin filaments in the spine head are very dynamic and show a high turnover by 
continuous treadmilling (Star EN, et al., 2002; Cingolani LA & Goda Y, 2008). 
Polymerization of G-actin and disassembly of F-actin induce rapid changes in the 
cytoskeleton, enabling morphology and functional modifications of dendritic spines 
(Cingolani LA & Goda Y, 2008).   
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In cells, actin filaments are commonly assembled into extended structures such as 
branched networks and bundles. A study by Koroba & Svitkina 2010, characterized the 
molecular architecture of the synaptic actin cytoskeleton. In this study, using platinum 
replica electron microscopy, spine heads were observed to contain branched dense 
networks of cross-linked actin filaments, while spine necks were found to have loosely 
arranged actin filaments. The spine base presented long actin filaments (see Figure 3 
for a model) (Koroba F & Svitkina T, 2010). This finding illustrates an essential role of 
the treadmilling of F-actin in regulating the morphology of dendritic spines as well as 







Figure 3| Model for F-actin organization in dendritic spines. Actin filaments (blue) are 
organized forming different networks: linear and branched anchored to microtubules (red) or 
actin filaments in the dendritic shaft (Figure from Koroba F & Svitkina T, 2010) 
 
1.3 Actin-binding proteins 
 
Actin-binding proteins have been identified as important modulators of spine 
morphogenesis and maintenance. They promote actin polymerization and 
depolymerization. Actin-binding proteins can be organized in three main groups with 
severing, stabilizing and modulating activity, respectively (Cingolani LA & Goda Y, 
2008; Lin W & Webb DJ, 2009). Examples of severing proteins are cofilin 
(Andrianantoandro E, et al., 2006) and gelsolin (Coué M & Korn ED, 1985). They are 
molecules capable of binding F-actin and breaking it down into smaller pieces thus 
playing an important role in the maintenance of the G-actin pool required for new 
assembly (Star E et al., 2002).  In contrast, the second group of stabilizing actin-binding 
proteins prevent F-actin to lose or add G-actin to already existing actin filaments, thus 
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stabilizing the actin cytoskeleton. This is the case, for example, for Eps8 (Menna E et 
al., 2009), that also functions as an actin-capping. Profilin is an example for proteins 
promoting actin polymerization (Ackermann and Matus, 2003). Finally, proteins such 
as α-actinin (Grazi E et al., 1992), CaMKII (Lin YC & Redmond L, 2008) and the 
developmentally regulated brain protein DBN modulate actin organization, affecting 
spine structure and function, by bundling or cross-linking actin filaments (Takahashi H 
et al., 2003; Lin W & Webb DJ, 2009). Numerous findings indicate that the actin 
signaling pathways in spines are regulated by many synaptic receptors including, for 
example, NMDA and AMPA receptors. They have been suggested to regulate the 
formation of the actin cytoskeleton mainly by mediating the influx of Ca2+ ions into 
postsynaptic neurons and by binding directly to actin-binding proteins (Hotulainen P & 
Hoogenraad CC, 2010). In addition to synaptic receptors, other actin-regulating 
proteins, such as receptor tyrosine kinases and synaptic adhesion molecules, have 
been described as important regulators of synapse function, but it is through multiple 
signaling pathways and tightly controlled regulation that actin-binding proteins 
modulate actin cytoskeleton dynamics in spines. GTPases of the Rho family and 
serine/threonine kinases regulate actin polymerization by targeting actin-binding 
proteins such as ProfilinII, CaMKII and ADF/Cofilin. Many of these proteins, which are 
modulating actin meshwork in dendritic spines, are regulated by phosphorylation (Da 
Silva JS & Dotti CG, 2002), a common post-translational modification.  
 
1.4 Drebrin  
 
Three DBN isoforms were first discovered in the chicken embryo brain by two-
dimensional gel electrophoresis (Shirao T & Obata K, 1985). Later, two different DBN 
isoforms were described in mammals: an embryonic form or DBN-E (~115kDa) and an 
adult form or DBN-A (~125kDa) (Shirao et al., 1987).  In the DBN proteins five domains 
have been identified: an N-terminal ADF homology domain, a coiled coil helical domain 
where an actin binding domain (Grintsevich E. Elena, 2010) is located, a proline-rich 
region suggested to regulate an interaction with profiling (Mammoto et al., 1998) and 
C-terminal Homer-binding domains (Shiraishi-Yamaguchi et al., 2009) (Figure 4).  
Moreover, the DBN gene is regulated in a developmental manner: Drebrin E is 
replaced by Drebrin A in the adult brain (Kojima et al., 1993).  





Figure 4| Diagram of Drebrin alternative splicing isoforms and domains. A) DBN is found in 
two isoforms produced by alternative splicing. DBN-A mRNA differs from DBN-E mRNA only 
by the presence of a 138-nucleotide sequence insert codifying for 46 amino acids depicted in 
the diagram. The protein domains of the two Drebrins are represented in this figure. By the N-
terminus an ADF/cofilin domain (blue), a coiled coil region (green) where the actin binding 
domain (yellow) is located, a prolin rich region (orange) and two homer binding domains by the 
C-terminus region.  B)  13 of the 17 phosphorylation sites that have been identified in the 
Drebrin protein are listed here.   
1.5 Drebrin regulation 
 
Post-translational modifications have been described to provide regulatory 
mechanisms for protein function. One common type of post-translational modification 
is phosphorylation involving the addition of a phosphoryl group. Phosphorylation of 
proteins can control different processes such as providing on and off switches of 
enzymatic activity, protein complex formation, protein localization, protein stability and 
turnover. DBN is a highly phosphorylated protein – to date 17 phosphorylation sites 
have been identified. These sites have been found by analysis of brain samples and 
cell lines using mass spectrometry (Ballif et al., 2004; Beausoleil et al., 2008; Chew et 
al., 2005; Molina et al., 2007; Olsen et al., 2006; Rush et al., 2005; Vosseller et al., 
2005; Wollscheid et al., 2005; Zheng et al., 2005) 
It has been shown that DBN is an actin-binding protein that modulates actin bundling 
and inhibits the interaction between F-actin and other actin-binding proteins such as α-
actinin, fascin (Sasaki Y et al., 1996), tropomyosin and myosin (Ishikawa R et al., 2007; 
Hayashi K et al., 1996; Ivanov A et al., 2009). In adult neurons, DBN accumulates in 
spine heads enriched in actin that have formed long filamentous structures. It has been 
suggested that DBN modulates synaptic plasticity by affecting the morphology of 
dendritic spines and by regulating neuronal transmission (Hayashi K et al., 1996; 
  Introduction 
9 
 
Hayashi K & Shirao T, 1999; Ivanov A et al., 2009; Aoki C et al., 2009). Additionally, it 
has been reported that DBN induces the synaptic clustering of the post-synaptic 
density scaffold protein (PSD-95), supporting its role in synaptic plasticity (Takahashi 
H et al., 2003). Interestingly, it has been shown that increasing the expression levels 
of DBN in neurons promotes spine elongation, whereas down-regulation of DBN 
reduces spine density (Mizui T et al., 2005; Takahashi H, et al., 2006).  
Drebrin A (DBN-A) was described to be neuronal specific, therefore, in order to 
investigate the role of DBN-A in neuronal function, an overexpression model was 
generated by the Shirao group in Japan (Gunma University, Graduate School of 
Medicine). Morphological analysis of hippocampal neuronal cultures upon DBN-A 
overexpression, resulted in elongation of dendritic spines while the overexpression of 
a DBN-A mutant lacking the actin binding domain did not have this effect (Ivanov et 
al., 2009b). This study showed that the actin-binding domain was responsible for the 
morphological phenotype of DBN-A in spines. Moreover, in the same study it was 
reported that the overexpression of DBN-A in neurons did not interrupt spontaneous 
synaptic activities in synapses. However, measurements of cumulative probability plots 
for amplitude and frequency showed a shift in the neurons overexpressing DBN-A 
having significantly higher values than in control neurons (Ivanov et al., 2009).  
In contrast to the overexpression effect of DBN on the morphology and function of 
neurons, downregulation of DBN-A with antisense oligonucleotides was reported to 
decrease the filopodia-spine density in comparison to the control but no changes in the 
elongation of the spines were detected (Takahashi et al., 2006). To further understand 
the functional role of DBN-A at the spines in neurons, a DBN-A knockout (KO) mouse 
model was generated. These animals presented deficits in homeostatic synaptic 
plasticity (Aoki et al., 2009). Further analysis of this mouse model showed that 
depletion of DBN-A impairs context-dependent fear learning (Kojima et al., 2010, 
2016). While the KO model is specific for DBN-A, the other isoform DBN-E is still 
present in the KO, that could lead to misinterpretation of the data where the lack of 
DBN-A together with the potential substitution of DBN-E could be responsible for the 
changes that are reported in these studies. However, more recently, the group of Prof. 
Dr. Gert Lubec reported for the first time morphological and functional analyses of a 
full DBN knockout mice. These animals lack both DBN isoforms and morphological 
analyses of this animal model show a reduction in spine number on dendritic segments 
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of CA1 apical pyramidal cells and CA1 hippocampal neurons and electrophysiological 
analyses confirmed that memory related synaptic plasticity was affected in these mice 
(Jung et al., 2015). 
Overall, the functional data for the role of DBN in neurons is still limited and further 
studies are required to clarify the function and regulation of DBN in the brain.  
1.6 DBN in ageing and disease 
 
The mammalian brain contains millions of specialized synapses -- interconnections 
between neurons generating neuronal networks. The first step in the formation of 
neuronal networks is the outgrowth of neuronal processes (i.e. presynaptic axonal 
terminals and postsynaptic dendritic regions, see Figure 1 for a schematic 
representation) which eventually enable the brain to perform complex tasks such as 
the formation of thoughts, memories, dreams, and learning (Shirao, 1995, Hotulainen 
P. & Casper C., 2010).   
Electron microscopy and electrophysiological studies have shown that cognitive 
decline during ageing is accompanied by a loss of thin spines, while no loss of 
mushroom or stubby spines has been observed. Thin spines have been strongly 
associated with plasticity. It is believed that they play a key role in the task of learning 
new information, whereas mushroom spines are thought to contribute to long-term 
memories and mediate strong synaptic currents. The role of stubby spines remains 
unclear (Morrison JH & Baxter MG, 2012). 
Proteins regulating spine morphology and maintenance are associated with cognitive 
impairment in ageing. This association was shown in a recent study where cognitively 
impaired by age or aged rats presented alterations in the expression of hippocampal 
proteins, which are normally responsible for synaptic-activity, signaling and structure. 
The proteins included MAP2, DBN, PSD-95 and CaMKIIα. Up-regulation of DBN 
significantly correlated with declining cognitive performance in aged impaired rats, 
indicating that a balance in the expression of the proteins, such as DBN, is essential 
for the maintenance of normal synaptic function during ageing (VanGuilder HD et al., 
2011).  
Neuronal dysfunction has been identified as hallmark in cognitive impairment and in 
neurodegenerative diseases, such as Alzheimer’s disease (AD) (Calon F et al., 2004). 
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Interestingly, an alteration in the expression levels of DBN has been observed in 
human hippocampal synapses in AD (Harigaya and Shoji, 1996). Other studies have 
shown that DBN levels decrease in brains of patients with AD and Down syndrome, 
thus supporting the hypothesis that DBN plays an important role in regulating synaptic 
activity in ageing and disease (Shim K S & Lubec G, 2002).   
Since ageing and neurodegenerative conditions have been shown to correlate with an 
imbalance in the expression of DBN, this result may suggest that a decline of DBN in 
dendritic spines may weaken synaptic connections, a common feature observed in 
ageing and various neurodegenerative disorders (Harigaya and Shoji, 1996; Shim KS 
& Lubec, 2002; Kojima et al., 2010). Supporting this hypothesis, Kobayashi and 
colleagues found that a reduction of DBN induced by antisense knockdown in the brain 
of rats causes cognitive deficits (Kobayashi H et al., 2004). However, the molecular 
mechanisms involved still remain unclear.  
 
Figure 5| Spine morphology maintenance under DBN turnover. A) Schematic representation 
of a neuron. Magnification represents a fragment of a dendrite where dendritic spines grow. B) 
Model for spine morphology after overexpression, normal or downregulation of DBN. Different 
phenotypes for dendritic spines have been described where DBN abundance plays important 
roles. The same phenotypes correlate with ageing and disease when DBN is downregulated.  
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1.7 Protein Turnover in neurons 
 
Protein turnover is the result of protein synthesis and protein degradation to maintain 
a steady-state protein abundance. This process is a key element for cell diversity and 
is regulated at different levels including: transcriptomics, metabolomics and proteomics 
(Doherty and Beynon, 2006).  
Different protein pools and the abundance in which they are found in specific 
compartments control synaptogenesis and dendritic spine morphology. Protein 
composition and concentration provide individuality to synaptic boutons (axons) or 
spines (Schuman, 1999). The protein diversity pools found at the synapse are 
maintained by two mechanisms taking place in neurons: localized transport and 
localized translation of mRNAs in the spines and axons. Localized translation, is often 
observed in polarized cells such as neurons. However, the most classic and better 
characterized example for transcript localization is the drosophila oocyte where the 
spatial distribution of mRNAs directs the early patterning of the anterior-posterior poles 
(reviewed by Schuman, 1999). Electron microscopy images of synapses allowed the 
identification of polyribosomes –mRNA and ribosome complexes- in dendritic shafts 
and at the base of spines (Ostroff et al., 2002), supporting the paradigm of mRNA 
localization and local translation in neurons. Moreover, deep sequencing of the 
Neuropil and high resolution in situ hybridization of neuronal transcripts (see Figure 6) 
in neurons clearly show the presence of more than 2000 transcripts in dendrites 
(Cajigas et al., 2012).  To date it is clear that mRNA translation in the soma of neurons 
is undoubtedly important, however increased evidence has been provided that support 
the functional significance of local protein synthesis. Local protein synthesis has been 
described to play a role in fundamental processes in neurons such as memory 
formation, dendrite and arbor branching, synapse formation, axon steering, cell 
survival and proteostasis (Tom Dieck et al., 2014).   




Figure 6I High-resolution fluorescent microscopy for detection of different mRNAs in primary 
neuronal cultures. This figure taken from Cajigas et.al, 2012 is an example for some of the 
evidence of localized transcripts in neurons. The red puncta represent the transcripts for the 
indicated genes found in dendrites and the panels are presented according to transcript 
abundance in dendritic shafts (top to bottom).  
On the other hand, protein degradation has been shown to play an important role in 
neurons. The ubiquitin proteasome system (UPS) is the main mechanism for protein 
degradation in the cell and is highly conserved among species from yeast to human 
cells (Yi and Ehlers, 2005). Moreover, protein ubiquitination and subsequent 
degradation is a very specific process acting in a spatial-temporal manner (Yi and 
Ehlers, 2005).  In the synapse, the UPS plays an important role in synaptogenesis and 
spine morphogenesis during activity-dependent spine outgrowth (Hamilton et al., 2012) 
and changes in spine morphology are known to underlie learning and memory (Engert 
and Bonhoeffer, 1999). These data provides evidence for the role of the proteasome 
regulating locally the growth of new dendritic spines. 
We know from previous work from the Eickholt lab that PTEN a protein and lipid 
phosphatase antagonizing the PI3K pathway interacts with DBN and that this 
interaction affects pS647-DBN levels. PTEN knock down in primary neuronal cultures 
increased pS647-DBN levels suggesting DBN regulation to be indirectly controlled by 
PTEN (Kreis et al., 2013). This observation was the first hint to hypothesize that 
perhaps DBN stability could be mediated by phosphorylation. DBN abundance is 
particularly interesting in the context of spine maintenance and synaptic function and 
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currently very little is known about how is DBN regulated. Moreover, downregulation 
of DBN has been observed in disease. Therefore, DBN turnover and stability in 




The main hypotheses this thesis addresses are: 
 
• Phosphorylation of DBN at S647 is important for the control of DBN turnover -- 
it is regulated by the phosphatase activity of PTEN.  
• DBN synthesis could be controlled by the PI3K-mTOR pathway and DBN 
degradation by the protein phosphatase activity of PTEN.  
• DBN turnover is likely to be controlled locally in dendrites and spines of neurons.   
• Spatial-temporal patterns of pS647-DBN could be relevant in the formation and 
maintenance of filopodia and dendritic spines.   
 
1.9 Phases and milestones of the project 
 
During the first year of my PhD project, I generated and tested several expression 
plasmids (DBN full-length and different phosphorylation mutants) that allowed me to 
examine DBN protein turnover in well-defined experimental settings. I mastered the 
techniques for introducing the constructs into different cell lines, in order to analyze 
morphometric changes and also for performing evaluations by western blotting. This 
was an essential step for fully understanding the specificity of a set of commercially 
available and in-house generated DBN antibodies. I also tested different protocols for 
inducing oxidative stress in mature primary neuronal cultures under clear experimental 
conditions, this to simulate neurodegenerative conditions in an in vitro model. Through 
these experiments I determined that an Abeta peptide preparation and paraquat can 
be applied in studies that unambiguously reduce DBN abundance in neurons and likely 
in cell lines too.   
In the second year of the project, I validated pulse-chase labeling protocols using 
metabolic labeling with the AHA, a methionine analog in order to study the stability of 
DBN depending on its post-translational modification. By the end of the year, the 
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relevant experiments were completed. They proved that one specific phosphorylation 
event at the DBN C-terminus (S647) is critical for controlling protein stability. Based on 
these findings, I continued my experiments in the laboratory of Prof. Erin Schuman of 
the Max-Planck Institute for Brain Research in Frankfurt. There, I acquired the 
expertise needed for applying a method that facilitates pulse-chase labeling of 
endogenous proteins and also the visualization of specific de novo synthesized 
proteins in cells. Initial characterization of the techniques validated them as a feasible 
approach for studying the spatial and temporal control of DBN turnover in neuronal 
primary cultures.  
In January of 2014, I started setting up the FUNCAT-PLA experiments in Berlin and 
modified the conditions for mouse neurons. I also initiated a collaboration with Viktor 
Dinkel, a bioinformatics student, with whom I developed a software plugin for semi-
automated analyses of PLA data. This plugin makes possible the systematic analysis 
of hundreds of confocal microscopy images. It was essential for obtaining the final 
quantifications and results for the different assays that I prepared applying PLA. The 
establishment of the technique, named FUNCAT-PLA, in the Eickholt Lab was 
accomplished at the end of the second and beginning of the third project years.   
During the course of the third year of the project, I made and completed the FUNCAT-
PLA experiments for studying DBN turnover in neurons. This assay provided 
information about the localization of the newly synthesized DBN proteins, showing that 
they could be translated locally in dendrites and spines. Therefore, in March of 2015, I 
went back to the Max-Planck Institute for Brain Research in Frankfurt and performed 
further experiments in neurons. By visualizing DBN transcripts in dendritic spines, I 
could confirm the presence of DBN mRNA in dendrites, providing additional support to 
the hypothesis that DBN is locally translated. While in Frankfurt, I also received training 
for applying Puro-PLA, an experimental technique that allows the visualization of 
specific proteins directly after translation with metabolic labeling using puromycin. 
During the course of my last project year, I established this technique in our lab and 
applied it to N1E neuroblastoma cells and primary neurons. The data obtained from 
the neurons confirms that DBN is not only translated in the soma of the neurons but 
also in dendrites, and possibly even in spines. I also applied this assay to study DBN 
translation after inhibition of the mTOR-PI3K pathway. I was able to show that mTOR 
inhibition reduces DBN translation in comparison to respective controls in 
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neuroblastoma cells under serum deprived conditions. Chapter 3 of this thesis provides 
the necessary experimental data and a discussion of these results. 
1.10 Organization of the experiments and methodology applied 
 
The main goal of this thesis project has been understanding the turnover and 
localization of the actin-binding protein DBN in neurons, and also determining the 
regulatory inputs for its stability. With these objectives in mind, some key experiments 
and the technology to be used were defined. The results of the thesis (in the next 
chapter) have been organized in three main sections that also present the 
methodology used in each experiment. 
 
Section 1: Regulatory inputs of DBN abundance in cell lines and neurons 
 
I started by investigating the expression levels for endogenous DBN in four different 
cell lines, as described in the first section of results. This was done with SDS-PAGE 
and western blot (WB) analyses. In the next step, I tested multiple antibodies against 
DBN, for their specificity in WB.  Then, in order to test different plasmids for DBN, I 
performed transfection in cell lines and analyzed the expression levels using SDS-
PAGE and western blotting (sections 2.1.1 and 2.2.2). 
In order to test the specificity of our DBN antibodies in immunocytochemistry, I cultured 
hippocampal neurons from DBN-KO embryos. I transduced these neurons with either 
YFP-DBN or only with YFP. This enabled me to determine the specificity of multiple 
DBN antibodies and to compare with the labelling in wild-type neurons (section 2.1.3). 
I applied the proximity ligation assay in order to obtain a direct visualization of the DBN-
PTEN interaction in neurons. This assay is an antibody based technology (first 
described in Söderberg, 2006) that allows the direct visualization of interacting proteins 
as close as 30-40 nm in fixed cells (section 2.1.4). 
In order to elucidate whether the phosphorylation site S647 of DBN plays a role in the 
formation of filopodia-like structures, I overexpressed YFP-DBNwild-type or the phospho-
mutants: YFP-DBNS647A or YFP-DBNS647D in multiple cell lines. These experiments are 
discussed in section 2.1.5.  
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I also explored possible mechanisms that control the abundance of DBN in neurons by 
analyzing DBN expression levels using western blotting, after the induction of oxidative 
stress with different compounds (section 2.2.2). With the same objective, I stimulated 
neurons with the antagonist for GABA A receptors and followed the expression of DBN 
over time using SDS-PAGE and western blotting (section 2.2.4) 
Section 2: DBN turnover 
Additionally, this thesis examines the characterization of the phosphorylation site S647 
and its potential role in the control of DBN turnover. In order to address this question, 
I developed pulse-chase experiments using metabolic labeling in cells overexpressing 
either Flag-DBNwild-type, Flag-DBNS647A (phospho-dead), or FlagDBNS647D (phospho-
mimetic). This allowed me to mark de novo synthesized proteins using pulse-labeling 
with AHA; a methionine analog. Their decay could be followed by chasing in complete 
medium. Click-chemistry allowed me to post-label with biotin the metabolically labeled 
proteins and their detection was then possible using streptavidin-HRP on a blot 
(section 2.2.1).  
The next project goal was to investigate the turnover of DBN in neurons and the 
resulting spatial-temporal patterns. To do so, I performed pulse-chase experiments 
with FUNCAT-PLA (Fluorescence Non-Canonical Amino acid Tagging and Proximity 
Ligation Assay) as described in Tom Dieck et al., 2015. This assay, allows the direct 
visualization of specific proteins after metabolic labeling in cells and it can be combined 
with chase in complete medium. These experiments are discussed in sections 2.2.2 
and 2.2.5. The FUNCAT-PLA provides microscopy images for quantitative analyses. 
Quantification required, the development of a semi-automated FIJI plugin with its 
description provided in section 2.2.4  
I also employed metabolic labeling with puromycin in order to address the question: 
how is DBN translation controlled? To answer this, I studied the regulation of DBN 
translation upon inhibition of the PI3K-mTOR pathway in combination with 
puromycilation and Proximity Ligation Assay or Puro-PLA as described in (Tom Dieck 
et al., 2015). These results are discussed in section 2.2.6 and 2.2.7. 
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Section 3: Visualization of DBN mRNA in neurons and abundance after neuronal 
stimulation 
The last section in the results chapter deals with the following questions: Where is DBN 
mRNA localized in neurons? Can its abundance and localization change when 
synaptic activity is blocked or enhanced?  Finally, I investigated the localization of DBN 
transcripts in neurons by in situ fluorescence hybridization (FISH) at basal conditions 
and upon stimulation with bicuculline (for enhancing synaptic activity), or TTX + APV 
(silencing synaptic networks).  These results are discussed in section 2.3.




2  Results 
 
2.1 Analyzing regulatory inputs of DBN abundance in cell lines and neurons 
 
This section describes the different treatments applied in experiments performed for 
establishing endogenous DBN presence in various cell lines and neurons. The 
overexpression of various DBN constructs was also tested. The main goal of these 
experiments was establishing models for studying DBN turnover, but also discovering 
regulatory inputs controlling the stability of DBN. Optimizing the parameters of this set 
of experiments turned out to be essential for the development of the more complex 
assays explained in the later sections.  
2.1.1 Analyses of endogenous and exogenous DBN expression by western blotting 
In order to investigate the endogenous expression of DBN, I prepared cell lysates from 
the following four cell lines that were continuously kept in culture:  
• HEK293T: human embryonic kidney cells expressing the SV40 Large T-antigen, 
• COS-7: fibroblast-like cell line derived from monkey kidney tissue,  
• N1E-115 (N1E): mouse neuroblastoma cell line, and  
• SH-SY5Y: human neuroblastoma cell line.  
The samples were analyzed using western blotting and were probed for DBN with two 
different antibodies (mouse monoclonal and guinea pig serum), with pS647-DBN and 
with GAPDH as loading control. I identified endogenous DBN expression in all four cell 
lines (Figure 7) to approximately similar levels. I also used our custom antibody for 
detecting pS647-DBN levels, and in fact in all four cell lines different levels were 
identified. Out of the four cell lines, HEK293T cells show the highest levels of pS647, 
while the SH-SY5Y cells have the lowest levels.  
The GAPDH bands have different sizes among four different cell lines shown in Figure 
7, which might be due to the differences in the species of different cells lines 
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Following overexpression experiments were pursued in HEK293T, chosen for being 
cells easy to transfect. N1E-115 cells were used for imaging experiments as good 
neuroblastoma model and for immunocytochemistry purposes.  
 
  
Figure 7| Endogenous DBN expression in cell lines.  Cell lysates from HEK 293T, COS-7, N1E 
and SH-SY5Y were collected and analyzed using western blotting. DBN was identified in all of 
the analyzed cell lines at similar levels, using two different pan-DBN antibodies (M2F6 mouse 
monoclonal and polyclonal guinea pig). In contrast, levels of pS647-DBN varied between the 
different cell lines. GAPDH was used as loading control. 
 
In the DBN literature little is known concerning the differences between the two DBN 
isoforms found in mammals. DBN-A and DBN-E are two different splicing isoforms of 
DBN. Whilst the overall amino acid sequence is almost identical, DBN-A (when 
compared to DBN-E) contains an extra sequence of 46 amino acids as shown in Figure 
4. At the protein expression level, it has been reported that DBN-E is replaced by DBN-
A in the brain tissue during development (Hayashi et al., 1998). Yet, no functional 
differences have been described to date. In order to gain some insights into the 
potential functional differences between DBN-A and DBN-E isoforms, I transfected 
HEK293T cells with tagged DBN constructs, and explored morphological changes by 
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microscopy and imaging analysis. First of all, I confirmed their expression at the protein 
level using western blotting after transfections (Figure 8). Secondly, I searched for 
differences in the phenotypes induced after DBN overexpression (Figure 14).   
Transfection of DBN-E and DBN-A, Myc-DBN-E, YFP-DBN-E, YFP-DBN-A, YFP, Flag-
DBN-E or Flag was performed and the expression was analyzed by western blotting 
using DBN and tag specific antibodies, as shown in Figure 8. all the different constructs 
were successfully transfected and were identified at the expected molecular weights. 
No band was found in non-transfected cells. The corresponding bands for those 
transfected with only YFP or Flag were not detected in these blots due to their small 
molecular weights. However, no band for DBN-tagged was found in the lysates from 
those cells transfected only with YFP and flag. Providing good controls for these 
experiments. Although we know that DBN is indeed express in HEK293T cells (see 
Figure 7), endogenous DBN was not always detected in the conditions where cells 
were not transfected with any construct or transfected with YFP, Flag. The reason for 
this is rather technical, the exposure time for detection of bands should be increased 











Figure 8| DBN overexpression with different plasmids. Cell lysates were analyzed by western 
blotting and blots were probed with DBN, GFP, MYC and FLAG specific antibodies, 
respectively, to identify exogenous DBN expression. Anti-GAPDH antibody was used as 
internal loading control. A) Transfected HEK293T cells with tagged DBN-E and DBN-A 
constructs as indicated. B) Transfected HEK293T cells with Myc-DBN-E or untransfected 
control cells. C) Transfected HEK293T cells with YFP-DBN-E, YFP-DBN-A or YFP. D) 
Transfected HEK293T cells with Flag-DBN-E or Flag.  
 
2.1.2 Determining the Specificity of DBN Antibodies in Immunocytochemistry 
Published DBN antibodies are commercially available, but specificity in 
immunofluorescence assays was nonetheless tested. This is especially important 
whenever the effect of the application of those antibodies is the main read-out of a 
particular assay. This is the case for example in techniques like immunocytochemistry 
(IC) and the proximity ligation assay (PLA). In the next section a detailed description 
of the PLA is provided.   
During my thesis project, I performed many antibody-based assays. Therefore, it was 
important to control for the specificity of the two pan-DBN antibodies that were applied 
for IC and PLA in this project. Those antibodies were the M2F6 DBN antibody (mouse 
monoclonal) and our custom made DBN antibody (rabbit polyclonal Eickholt lab). The 
DBN (Eickholt lab) is an antibody that is collected after serum purification of our pS647-
DBN antibody, and has been established to recognize total DBN. I tested the specificity 
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of these two DBN antibodies by performing immunocytochemistry in DBN-Knockout 
(DBN-KO) hippocampal neurons, using the DBN antibodies mentioned above.  
In our lab, Dr. Till Mack has generated a DBN-KO mouse model missing the exons 1-
6 of DBN, as described in the material and methods section. Cultured neurons from 
these animals should not produce any positive labeling for DBN when performing 
immunocytochemistry (IC) unless the DBN antibody being unspecific. 
To confirm the specificity of these antibodies I performed IC in cultured DBN-KO 
hippocampal neurons transduced with either YFP-DBN (Figure 9 A and B) or YFP 
lentiviruses (Figure 9 C and D). After 22 DIV the neurons were fixed and 
immunocytochemistry for the detection of DBN and MAP2; a somato dendritic marker 
was performed. Transduced neurons were identified by the expression of YFP. For 
those neurons transduced with YFP-DBN a co-localization between YFP and DBN 
staining was observed (Figure 9 A and B). In contrast, neurons missing DBN and 
transduced only with the YFP lentivirus control have no expression and staining of 








Figure 9| Control immunostaining for DBN antibodies in DBN-KO neurons. Cultured 
hippocampal neurons from DBN-KO mice were infected with YFP-DBN (A and B) or YFP (C 
and D) lentiviruses as indicated after 14 DIV and fixed at 22 DIV. Immunocytochemistry was 
performed using DBN (M2F6), or our homemade DBN rabbit antibody DBN (Eickholt lab) for 
DBN staining and MAP2 as a neuronal marker. The images are maximal projections; 
brightness and contrast has been manually modified for visualization purposes.  Scale bar: 20 
µm. 
Moreover, DBN localization is known to be enriched in dendritic spines and to co-
localize with F-actin. Therefore, it can be used as a postsynaptic spine marker. F-actin 
forms the actin cytoskeleton in neurons and it is usually complex and enriched in 
dendritic spines. In order to visualize the localization of DBN, using both of the 
antibodies tested above, I performed IC for DBN and MAP2 in wild-type neurons 
(Figure 10 A and B). In these pictures it is evident that DBN decorates the dendrites 
as synapses would do. In order to confirm this localization, I performed IC for DBN and 
F-actin wild-type neurons, using both DBN antibodies (Figure 10 C and E). DBN has 
been shown to be enriched in dendritic spines and to accumulate in areas where F-
actin is highly abundant. As shown in Figure 10 C and E, DBN is indeed found in 
dendritic spines and it highly co-localizes with F-actin in these neuronal compartments. 
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This is evident by the presence of the yellow color; consequence of the merge between 
green (F-actin) and red (DBN).  
 
Figure 10| Localization of DBN in neurons from wild-type mice. Cultured hippocampal neurons 
from wild-type mice were fixed after 22 DIV and stained with DBN (M2F6) (A and C) or DBN 
(Eickholt Lab) (B and E) antibodies (red). An antibody against MAP2 was used as a neuronal 
marker to distinguish neurons from non-neuronal cells (blue) in A and B and phalloidin was 
used to label F-actin in C, D and E. The images are maximal projections; brightness and 
contrast has been manually modified for visualization purposes. Scale bar: 20 µm.  
2.1.3 Visualization of DBN and PTEN interaction in neurons 
Kreis et.al. (2013) identified DBN as an interaction partner of PTEN. The interaction 
was detected in the rat brain by mass spectrometry analysis and it was confirmed by 
co-immunoprecipitation. The interaction was further characterized in overexpression 
systems in PC12 cells using multiphoton fluorescence-lifetime imaging microscopy. 
Moreover, experiments with hippocampal rat neurons cultured for 18 DIV and stained 
with anti-pS647-DBN and PTEN antibodies, showed that PTEN is mainly found in 
dendrites and only occasionally in spines, while pS647-DBN is highly concentrated in 
spines. In this paper, anti-DBN antibody labelling, as well as labelling using the anti-
pS647-DBN antibody, demonstrated some co-labelling with anti-PTEN antibody in 
cultured neurons.  One of the main observations was that whenever PTEN was 
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detected in spines, pS647-DBN was missing. These results suggested that PTEN and 
pS647-DBN segregate into complimentary compartments, supporting the idea that 
PTEN can negatively regulate pS647-DBN in neurons (Kreis et al., 2013). 
In order to further explore the localization of the PTEN-DBN interaction in neurons, as 
well as to establish a new platform in which we can test if the interaction is of direct 
nature, I performed a proximity ligation assay in cultured hippocampal neurons as 
shown in Figure 12 A for PTEN and DBN.  
Several methods for visualizing protein interactions in situ have been developed during 
the last decades. In order to visualize direct protein-protein interaction in cells, most 
approaches rely on the overexpression of genetic constructs, and they have been 
successfully used in assays of living cell maintained in tissue culture as well as in fixed 
cells (Hu et al., 2002; Jares-Erijman and Jovin, 2003). However, most of these assays 
involve the introduction of exogenous proteins.  
I wanted to investigate the interaction between DBN and PTEN at endogenous levels 
in normal conditions. To do so, I applied the proximity ligation assay or PLA; an assay 
that offers the possibility for the direct visualization of specific protein-protein 
interactions that are in the proximity of 30 nm (Söderberg et al., 2006). The PLA is an 
antibody based assay, combining proximity ligation with rolling circular amplification 
(RCA). The PLA probes consist of species-specific antibodies coupled to linear 
oligonucleotide sequences that in the proximity and the presence of a ligase will 
catalyzed the ligation between the two ends in proximity.  RCA is directed by a 
polymerase and the addition of fluorescence labeled oligonucleotides complementary 
to the PLA probes. A schematic representation of this assay in depicted in Figure 11.  
 




Figure 11| Schematic representation of the PLA for DBN and PTEN. A) The PLA assay is an 
antibody based assay. In order to visualize the interaction between DBN and PTEN antibodies 
specific to these proteins as well PLA– -mouse and PLA+-rabbit probes were applied. B) In this 
diagram 1-5 provides a guide to the general procedure conducted for the detection of the DBN-
PLA complex in neurons using PLA.   
In order to detect and visualize the endogenous interaction between DBN and PTEN, 
the PLA in 18-21 DIV cultured hippocampal neurons using anti-DBN and anti-PTEN 
antibodies was performed, according to the manufacturer’s manual. Following the 
amplification reaction, cells were then stained with an anti-MAP2 antibody to establish 
the general outline of the soma and dendrites, and to exclusively label neurons (Figure 
12). These experiments resulted in puncta from the PLA reaction that were found in 
close proximity to MAP2 positive dendrites. In order to control for the specificity of this 
approach, I undertook three sets of control experiments. In the first, both primary 
antibodies were omitted, whilst in the second and third, neuronal cultures were labeled 
with the PTEN antibody only or the DBN antibody only. In all experiments, the 
secondary antibodies were used. The PLA in these experiments resulted in no puncta, 
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indicating the specificity of the approach in detecting PTEN-DBN interaction. This is 
the first time that PTEN-DBN interactions have been visualized at endogenous levels 
in neurons.  
 
Figure 12| PTEN-DBN interaction in neurons. PLA for DBN and PTEN was performed in fixed 
18-21 DIV mouse neurons. A) PLA controls for the visualization of the PTEN-DBN interaction 
in neurons applying PLA. The first row of images shows the interaction between PTEN-DBN 
(red) in neurons. The second, third and fourth rows, show that in the absence of one or both 
of the antibodies in the PLA assay, the interaction is not detected, proving the specificity of the 
signal in the assay. The neuronal marker MAP2 is shown in green, the PTEN-DBN interaction 
in red and Hoechst in blue. Scale bar: 20 µm 
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In order to unequivocally localize the obtained PLA signals to dendritic spines, I also 
performed the assay and co-labelled with F-actin. As demonstrated in Figure 13, some 
puncta co-localize to F-actin rich dendritic spines. However, only a minority of spines 




Figure 13| Visualization of PTEN-DBN interaction in neurons with PLA. A) PLA for DBN and 
PTEN (yellow) in co-localization with F-actin (red) in neurons. B) Visualization of the presence 
of the PTEN-DBN complex in spines (PLA). F-actin is stained in green, MAP2 in magenta, 
Hoechst in blue, and the PTEN-PLA complex in yellow. This staining shows the presence of 
the PTEN-DBN complex in dendrites and base/neck of spines. Scale bar: 20 µm 
2.1.4 DBN biological role in the formation of filopodia-like structures when 
overexpressed in cell lines.  
As an F-actin binding protein, DBN overexpression has been reported to induce 
filopodia-like structures in a number of different cell types and cultured neurons 
(Hayashi and Shirao, 1999; Mizui et al., 2005). In order gain first insights into the 
potential effect of the phosphorylation site of DBN in cells, I exploited a cell line based 
assay to monitor filopodia formation using YFP-tagged wild-type isoforms DBN A and 
E as well as of amino acid substitutions mimicking a dephosphorylated state (DBN 
S647A for the adult form and in the site S601A for the embryonic form).  COS-7 cells 
(Figure 14-A) or SH-SY5Y (Figure 14-B) cells were transfected with the individual 
constructs and were then fixed after 24 h, before stained for microtubules with anti-
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tubulin and nuclei with Hoechst. Representative confocal microscope images are 
shown in Figure 14. 
In cells overexpressing DBN-A, there was a clear induction of a prominent filopodia 
phenotype, similar to the results reported by Hayashi and Shirao (1999) in CHO cells. 
Here, overexpression of DBN-E, as well as the mutant DBN S647A/S601A constructs 
induced filopodia to the same extend as DBN-A.  Therefore, S647/601 is not likely to 
influence DBN activity toward influencing actin dynamics during filopodia induction, at 
least not in this assay.  
 
Figure 14| Overexpression of DBN induces the formation of filopodia-like structures. A) COS-
7 and B) SH-SY5Y cells were transfected with either YFP-DBN-E, YFP-DBN-E-S601A, YFP-
DBN-A, YFP-DBN-A-S647A or an YFP control, as indicated and labeled in green for 24 h. As 
an extra control non-transfected cells are included. After transfection, cells were fixed and 
stained for tubulin in red and Hoechst in blue. The images were captured using a confocal 
microscope.  
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2.1.5 Induction of oxidative stress by paraquat reduces DBN expression levels in 
cortical neurons 
The production of reactive oxygen species (ROS) is consequence of the metabolism 
of the cell, however when the ROS present un-pair electrons they are known as free 
radicals. Free radicals are highly reactive molecules that can affect important 
processes in the cell leading to cell dead (Ramalingam and Kim, 2011). An increase in 
the production of ROS has been described to contribute in the pathogenesis of some 
diseases including AD (Ramalingam and Kim, 2011). In connection to this, multiple 
studies have reported a decrease on DBN protein levels in the brains from AD patients 
suggesting a possible correlation between DBN levels and cognitive impairment  
(Counts et al., 2012; Harigaya and Shoji, 1996; Shim and Lubec, 2002). However, clear 
evidence about how DBN influences AD disease remains to be elucidated.   
I hypothesized that DBN may be modified by oxidative stress. Therefore, I investigated 
whether DBN levels decrease during oxidative stress by challenging matured cortical 
neurons testing three compounds commonly used for the induction of oxidative stress 
in cells: H2O2 and the herbicide paraquat (Wang et al., 2009; Doré et al., 1999; 
Ramalingam and Kim, 2011). In addition to those compounds, Aβ the Alzheimer’s 
disease related protein was also tested.  
In order to assess DBN stability during conditions that may resemble aged or disease-
like insults and to find the right experimental conditions, H2O2, paraquat and Aβ were 
applied at different concentrations. I observed that H2O2 at the tested concentrations 
(1-10 µM) had no effect on DBN protein levels in 14 DIV cortical neurons. Treatments 
with Aβ applied (0.25µM-2µM) were rather difficult since occasionally the effect was 
very toxic leading to neuronal death.  However, the herbicide paraquat significantly 
reduced DBN protein levels in a 20 µM concentration with no cytotoxic effects (Figure 
15), providing a good platform for future experiments targeting the regulation of DBN 
abundance during oxidative stress.  These data demonstrate that levels of DBN are 
vulnerable to increased oxidative stress providing a good experimental setup for future 
investigations.  




Figure 15| Induction of oxidative stress by paraquat reduces DBN levels in 14 DIV cortical 
neurons. Mouse embryonic day 16.5 (E16.5) cortical neurons were cultured for 14 days in vitro 
and were treated with different concentrations of paraquat. Twenty-four hours after treatment, 
the cells were lysed and analyzed for DBN levels (A). Equal amounts of lysates were loaded 
on 8% poly-acylamide gels and were probed for DBN and GAPDH. B) The relative levels of 
DBN were quantified and normalized to vehicle control levels. These values are plotted for 
three independent experiments, where the error bars represent +/- SEM and *p=0.010 
2.2 Regulation of DBN turnover 
 
This section describes the experiments I performed in order to study the potential role 
of DBN phosphorylation at (S601) in the stability of the protein. I designed and 
established pulse-chase experiments using metabolic labeling with AHA. These 
experiments allowed me to study the degradation and turnover profiles of Flag-DBNwild-
type and two Ser-substituted mutant forms, mimicking either a dephosphorylated (Flag-
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2.2.1 Pulse-chase experiments using L-Azidohomoalanine in a cell culture system 
show that pS647 regulates DBN stability 
Cell homeostasis is a process highly dependent on the proteome. The proteome is 
very dynamic and it is regulated by protein synthesis and protein degradation. This 
regulation is implicated in several biological processes such as cell proliferation, cell 
growth, cell differentiation, cell metabolism, memory and learning (Dieterich et al., 
2006). Therefore, understanding the means for proteostasis can provide insights into 
the regulation of such processes. DBN is a protein which has been described to play 
a role in synaptic plasticity (Jung et al., 2015) and which protein levels seem to be 
important in the regulation of filopodia formation and spine maintenance (Hayashi and 
Shirao, 1999; Kreis et al., 2013).  
DBN is a highly phosphorylated protein and site-specific phosphorylation is speculated 
to regulate localization and stability of DBN. Therefore, I explored DBN turnover in 
dependence of S647/S601 phosphorylation, a phosho-site shown by Eickholt and 
colleagues to be regulated by PTEN levels (Kreis et al., 2013). To do so, I applied 
bioortogonal noncanonical amino acid tagging (BONCAT) (Dieterich et al., 2006).  
BONCAT was developed by Schuman and colleagues (2006) for the identification of 
newly synthesized proteins in mammalian cells using metabolic labeling with AHA. 
Application of assays such as isotope labeling amino acid, 2D gel electrophoresis, 
radioactive isotope labeling amino acid and others had been applied before for this 
purpose (Dieterich et al., 2006). However, BONCAT opened the possibility of enriching 
labeled de novo synthesized proteins. This is possible with AHA and ‘click-chemistry’ 
for the alkyne-biotin cycloaddition.  




Figure 16| Overview of the experimental setup for pulse-chase experiments using metabolic 
labeling. A) Chemical structure of the methionine analog L-azidohomoalanine. B) Chemical 
structure of the aminoacid methionine. C) Flow chart of the protocol for pulse-chase 
experiments. 293T cells were transfected and later pulse-labeled with AHA. Cells were lysed 
and click-chemistry was performed. Detection of AHA-labeled proteins was performed with 
streptavidin-HRP in western blot.   
AHA is an unnatural amino acid that is incorporated into newly synthesized proteins 
instead of Methionine (Met) during pulse-labeling. This principle was used to label 
expressed protein over defined periods of time, chasing them with complete medium 
for studying the labelled protein’s stability. As shown in Figure 16, HEK293T cells were 
transfected and, after 24 h, Met starved for 1 h and pulse-labeled with 1 mM AHA for 
1 h. Then, cells were lysed and click-chemistry was performed. Samples were 
analyzed by WB, whereby the detection of the AHA-labeled proteins was performed 
with streptavidin-HRP. 




Figure 17| DBN protein stability is pS647 dependent. HEK293T cells were transfected 24 h 
after platting with DBNWT-Flag, DBNS647A-Flag, DBNS647D-Flag or Flag. 24 h after transfection 
cells were methionine starved for 1 h followed by pulse-labeling with L-azidohomoalanine 
(AHA) for 1 h and chased in complete medium for 0, 24, 48 or 72 hrs. Cell lysates were 
collected and used for click-chemistry (alkyne-biotin cycloaddition). Pellets were resuspended 
in sample buffer and analyzed by western blotting using streptavidin for the detection of AHA 
labeled proteins or the indicated antibodies. A) Pulse-chase experiments comparing DBNWT-
Flag and DBNS647A-Flag protein stability or B) DBNWT-Flag and DBNS647D-Flag protein stability 
by western blotting. C-D) Western blots were quantified and relative protein abundance after 
normalizing to loading control (tubulin) and to time point 0 h is plotted. Pointed lines indicate 
the respective exponential decay curves and error bars show the SEMs.*P-value= 0.070 
These experiments show that DBNS601A is degraded faster than the DBNwild-type isoform 
(Figure 17). This observation suggests that the stability of DBN is S601 
phosphorylation dependent. In contrast, DBN mutant isoform mimicking a 
phosphorylated state (S601D) is as stable as the wild-type DBN-E isoform after 72 h 
chase (Figure 17). In addition, I estimated protein half-lives for all the DBN proteins: 
wild-type and mutants (Figure 18). The protein half-lives indicate that DBN is a long-
lived protein and that ablating DBN S601 phosphorylation increase its turnover (half-
live=39 +/-3 hours). Moreover, the half live of DBNwild-type does not differ significantly 
from the half live of DBNES601D (75 ± 8 hours and 97± 16 hours, respectively), indicating 
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that DBN is highly phosphorylated under normal conditions. These results suggest that 
DBN stability is dependent on S647 phosphorylation. 
 
 
Figure 18| DBN protein stability is pS647 dependent. A) HEK293T cells were transfected 24 
h after platting with DBNWT-Flag, DBNS647A-Flag or DBNS647D-Flag. 24 h after transfection 
cells were methionine starved for 1 h followed by pulse-labeling with L-azidohomoalanine 
(AHA) for 1 h. Cells where then chased in complete medium for 0 and 72 h. Cell lysates were 
collected and used for click-chemistry (alkyne-biotin cycloaddition). Pellets were resuspended 
in sample buffer and analyzed by western blotting using streptavidin-HRP for the detection of 
AHA labeled proteins or Flag-specific antibody to detect total exogenous gene product. A) 
Representative western blot showing time points 0 and 72 h chase. DBN AHA-labeled proteins 
are detected with streptavidin-HRP. Less AHA-labelled DBNS647A-Flag is present after 72 h 
chase compared to DBNWT-Flag and DBNS647D-Flag. B) and C) Protein half-lives were 
calculated from quantification of three independent experiments and are plotted in this bar plot 
C) The half-lives indicate that DBN is a long-lived protein and that ablating DBN S647 
phosphorylation increases its turnover. Error bars indicate SEMs and * indicates P-value < 
0.01. 
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2.2.2 Proteasome inhibition in pulse-chase experiments reveals that DBN is degraded 
via the Ubiquitin Proteasome System 
Cellular control of protein degradation involves a number of different mechanisms. For 
example, membrane proteins are proteolytically cleaved in the lysosome compartment 
whilst most cytosolic proteins are degraded by the proteasome. Since I was studying 
the degradation profiles of DBN and the regulation of its stability, the connected 
question arose: how is DBN degraded in the cell?  
At the time of this investigation there was no data in the literature providing any 
evidence about the mechanisms for DBN degradation. Therefore, a viable first 
approach was to apply a proteasome inhibitor, MG132, in the already developed pulse-
chase system and follow DBN degradation in the presence or absence of such 
inhibitor. Later, Chimura et.al. (2015) published that DBN degradation is calpain 
mediated during cytotoxicity with NMDA. 
Pulse-chase experiments in which MG132 was applied during the chase resulted in a 
change in the turnover of DBN. As shown in Figure 19, DBN was stabilized when the 
proteasome was inhibited during the 24 and 48 h chases. Quantification of 2 
independent experiments was performed and relative protein abundances for DBN-
wild-type and DBNS647A are plotted in the bar plot of Figure 19. These analysis show 
that both isoforms are stabilized when the proteasome is inhibited, suggesting a 
degradation via UPS.  
In order to further investigate the degradation of DBN, ubiquitin assays for DBN were 
performed in collaboration with Dr. Patricia Kreis (Postdoc in the Eickholt lab). The 
results support the idea that DBN is degraded, at least partially, via UPS (these 
experiments are not reported in this thesis).   
  




Figure 19| DBN degradation is proteasome dependent. A) HEK293T cells were transfected 
24 h after platting with DBNWT-Flag, DBNS601A-Flag or Flag. 24 h after transfection, cells 
were methionine starved for a period of 1 h followed by a pulse-labeling with AHA for 1 h and 
chase in complete medium for 24 or 72 h in the absence (control) or presence of 1 µM MG132. 
B) Cell lysates were collected and used for click-chemistry (alkyne-biotin). Samples were 
analyzed by western blotting using streptavidin-HRP and the specified antibodies. C) Western 
blot quantification representing two independent experiments of streptavidin normalized first 
to loading control (α-tubulin) and 24 h chase DBN-WT control, which equals maximum 
labelling. D) Western blot quantification representing two independent experiments of 
streptavidin normalized first to loading control (α-tubulin) and 24 h chase DBN-S601 control, 
which equals maximum labelling. Data from two independent experiments is shown.  
2.2.3 Studying DBN turnover in neurons. 
We asked how DBN abundance is regulated. To answer this question, we studied DBN 
turnover in pulse-chase experiments. These experiments suggest that DBN is a long 
lived protein with an estimated half-live of 3 days. Moreover, we were able to show that 
the stability of DBN is controlled by the phosphorylation of S647 (S601), located at the 
C-terminus of the protein. To further confirm these results we searched for an 
experimental approach that could allow us studying DBN turnover at the endogenous 
level in neurons.  We collaborated with Prof. Dr. Erin Schuman (Max Planck Institute 
for Brain Research, Frankfurt am Main) to perform FUNCAT-PLA (Fluorescence Non-
Canonical Amino acid Tagging- Proximity Ligation Assay) in neurons in order to get 
more insight into DBN stability in neurons. In this section the results for these analyses 
are presented.  




2.2.3.1 Visualization of de novo synthesized proteins in vitro with FUNCAT-PLA 
in neurons  
FUNCAT-PLA (Tom Dieck et al., 2015) combines two different techniques – FUNCAT: 
Fluorescence non-canonical amino acid tagging (Dieterich et al., 2010) and PLA:  
proximity ligation assay (Söderberg et al., 2006). Combined they help to visualize the 
synthesis of specific proteins at the single molecule level in fixed cells. FUNCAT is a 
method that allows the visualization of newly synthesized proteins after metabolic 
labeling with AHA. This assay was introduced by Schuman and collaborators (Dieterich 
et al., 2010).  
Using FUNCAT-PLA, the abundance and localization of newly synthesized individual 
proteins can be quantified. In addition, it can be combined with variable chase periods, 
making it possible to study the turnover of specific proteins. Our focus is on DBN; 
therefore I applied FUNCAT-PLA to study the spatial-temporal localization of newly 
synthesized DBN in neurons (Figure 22). As exemplified in Figure 20, Click-chemistry 
is performed on fixed cells, covalently linking the newly synthesized AHA bearing 
proteins to biotin. The nascent proteins can later be detected using a fluorophore–
coupled antibody against biotin. PLA, which traditionally has been used for the 
visualization of individual protein-protein interactions by proximity ligation at various 
subcellular structures, can be used to label specific proteins that have incorporated 
AHA during a pulse of 2 h. This is achieved, using the anti-biotin antibody in 
combination with an antibody against the protein of interest (e.g. anti-DBN). 
The diagram in Figure 20 shows the seven general steps of the protocol:  
1. Pulse-labeling with AHA. 
2. Click-chemistry (alkyne-biotin). 
3. Incubation with primary antibodies (E.g. DBN and Biotin). 
4. Incubation with PLA probes (anti-mouse- and anti-rabbit+). 
5. Ligation. 
6. Rolling circular replication. 
7. Microscopy imaging for detection of red fluorescent signal. 




Figure 20| FUNCAT-PLA Scheme. This scheme shows the principle behind the technique that 
was applied for the direct visualization of DBN in neurons. Using metabolic labeling, cells were 
pulse-labeled with the non-canonical amino acid AHA (1). AHA intercalates into newly 
synthesized proteins instead of methionine labeling nascent proteins. Click-chemistry for 
alkyne-biotin cycloaddition is then performed on the fixed cells, covalently linking the newly 
synthesized AHA bearing proteins to biotin (2). Anti-DBN (mouse) and anti-biotin (rabbit) 
antibodies are applied (3), followed by the incubation with the anti-mouse MINUS and the anti-
rabbit PLUS PLA probes (4) Secondary antibodies coupled to a short and unique 
oligonucleotide sequence. Upon close proximity (<40nm) the PLA probes will come together 
in a ligation step (5). This interaction between the two DNA strands can then be amplified by 
performing a rolling circular replication in the presence of a polymerase and fluorescent-
coupled deoxyribonucleotides (6). In the end the signal is observed as red puncta representing 
the novo protein synthesis (7).   
 
2.2.3.2 Development of automatic FUNCAT-PLA analysis 
For quantitative evaluations of PLA signal systematic analyses of multiple confocal 
microscope images became apparent. Therefore, we developed a JAVA program for 
the quantitative analysis of the PLA signal in confocal images, in a semi-automated 
way. This program was developed under my supervision with Viktor Dinkel, which 
formed essential part of his BSc project (thesis advisor: Prof. Raul Rojas, Department 
of Mathematics and Computer Science, Freie Universität Berlin).  
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The original sequence for the analysis of the PLA distribution in cells was created by 
Lisa Kochen (Department of Synaptic Plasticity, Max Planck Institute for Brain 
Research). Using her sequence, we further optimized the analysis in order to increase 
its rigor.  We developed a systematic approach for quantifying our results. The program 
is optimized to process multiple images from a given folder with an approximate 
processing time of 10-20 seconds per image. At the end of the analysis, the program 
provides a summary report for individual images that includes the following data: 
a. Raw image file. 
b. Images for individual channels. 
c. Mask for cell volume marker (e.g.MAP2, tyr-tub or GFP). 
d. Values for the thresholds used. Thresholds can be chosen automatically or can 
be set manually.  
e. Values for total area occupied by the cell volume marker (e.g. MAP2 in neurons). 
f. Number of PLA puncta for each image and total area occupied. 
g. Fluorescent intensity for PLA signal. 
The image is further filtered to exclude puncta that are either non-overlapping with the 
cell volume marker, or are in close proximity (< 1 µm) to cover the area of the dendritic 
spines that are not label by MAP2. Finally, the ratio of the specific PLA signal area over 
the cell volume marker area are calculated and presented as a percentage of total cell 
area. This pipeline of image processing and data acquisition is repeated for individual 
images. The analysis is performed on maximal projections for one group of images 
with the same experimental condition and contains a summary table with the values 
for the thresholds used, the total number of images analyzed, the mean values for PLA 
and MAP2 areas, as well as the PLA/MAP2 mean ratio (as a percentage) for the group 
of images analyzed. In addition, the summary report allows us to return to the previous 
step during the evaluation process, for each image. All images, including masks, are 
individually stored for manual control in the analyses folder, if needed. An example of 
a summary report is presented in Figure 21.   
  




Figure 21| Report for PLA analysis of confocal images.  The report for a folder containing 
multiple images includes the complete analysis of the group, and also provides individual 
results for each image, as shown in this figure. The top panel is the report for the entire group, 
which in this case contains 5 images. The next panel is an example for one image, where the 
original image, the image for the MAP2 mask (cell volume marker) and the splitting of the 
channels is included. The report also contains the quantification for the total area occupied by 
MAP2 and by the number of puncta that have been counted. It gives the ratio PLA area over 
MAP2 area as a percentage, and shows the total number of puncta, both filtered and total. The 
blue letters are a link to an Excel file containing the quantification for all the images, where the 
complete data is organized in a table facilitating data analyses.  
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2.2.3.3 Visualization of de novo synthesized DBN in situ with FUNCAT-PLA in 
neurons  
DBN overexpression studies in HEK293T cells revealed that DBN stability is 
phosphorylation (S601) dependent. However, I wanted to know whether this also holds 
true for endogenous DBN in neurons. To study the turnover of DBN in neurons, I 
performed pulse-chase experiments with FUNCAT-PLA for DBN.  
To do so, rat hippocampal dissociated neurons (18-20 DIV) were pulsed-label with 
AHA for 2 h and chased for 15 min before fixation, as indicated in the schematic 
representation (Figure 22). PLA for biotin and DBN was followed on the fixed cells after 
click-chemistry. To evaluate the specificity of the labeling, two negative controls were 
prepared: a methionine control (met), whereby the complete medium contains 
methionine but no AHA, and an anisomycin control (aniso) where protein synthesis 
was blocked. Finally, staining of MAP2, a neuronal somato-dendritic marker was 
applied.  
These experiments indicated that the DBN pool, labeled for 2 h with AHA, is present 
both in soma and dendrite and that this signal is specific (Figure 22). The specificity 
was confirmed by quantitative analyses of the two control conditions: Met or AHA-aniso 
and compared to AHA. The signal in Met and AHA-aniso is 80 fold lower therefore 
considered as a background signal. These experiments were the bases for performing 
pulse-chase experiments applying FUNCAT-PLA for studying DBN turnover in 
neurons.  




Figure 22| FUNCAT-PLA for visualization of DBN synthesis in situ. A) 18-20 DIV primary 
neurons were pulse-labelled for 2 h with AHA and were fixed after a 15 min chase in complete 
conditioned medium. B) To follow DBN synthesis in situ click-chemistry (alkyne-biotin 
cycloadition) and PLA using antibodies against DBN and Biotin was performed on the fixed 
neurons. This was performed for the three FUNCAT-PLA control conditions: AHA-control, Met-
control and AHA-anisomycin. MAP2 is shown in magenta, PLA in yellow and DAPI in blue. C) 
Quantification of the PLA signal after MAP2 normalization as percentage of AHA-control (error 
bars indicate SEM from three independent experiments. Images were modified for visualization 
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2.2.3.4 DBN turnover and pS647-DBN kinetics in rat hippocampal neurons 
I performed pulse-chase and FUNCAT-PLA experiments in rat hippocampal neurons 
with the objective of studying DBN turnover in neurons. The degradation of DBN was 
followed for 24 h and 68 h after pulse-labeling as shown in the schematic 
representation in Figure 23.  Representative images of the experiments for 0 h, 24 h 
and 68 h chase are displayed on Figure 23. Quantification of these images from three 
independent pulse-chase experiments shown in Figure 23-C indicate that 
approximately 50% of the DBN protein is degraded after ~70 h, while no degradation 
occurs during the first 24 h. This is in line with my previous experiments performed in 
the lab using biochemical assays, which determined the half-life of DBN to be 75 ± 8 h 
in pulse-chase experiments.  
 
 





Figure 23| Pulse-chase experiments with FUNCAT-PLA to follow the spatio-temporal pattern 
of de novo synthesized DBN A) 18-20 DIV primary neurons were pulse-labelled with AHA for 
2 h and fixed after 0, 24 or 68 h chase in complete conditioned medium. B) To follow the spatio-
temporal patterns for newly synthesized DBN click-chemistry (alkyne-biotin) and PLA using 
antibodies against DBN and Biotin was performed on the fixed neurons. These was performed 
for the three FUNCAT-PLA control conditions: AHA-control, Met-control or AHA-anisomycin. 
(MAP2 is shown in green, PLA in red and DAPI in blue. C) Quantification of the PLA signal 
after MAP2 normalization as percentage of AHA-control (error bars indicate SEM of three 
independent experiments). Images were modified for visualization purposes. Protein half-live 
was calculated assuming an exponential decay degradation. Scale bar: 20 µm.  
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2.2.4 Deciphering DBN translation control and localization in situ in neurons 
It has become clear that several synaptic proteins are locally translated in dendrites 
and synapses (Tom Dieck et al., 2014). Moreover, polyribosomes have been identified 
in the dendritic shafts and spines, which suggests a role of local protein synthesis in 
the regulation of synapses (Ostroff et al., 2002). Furthermore, it has been proposed 
that synaptic plasticity requires synthesis of proteins and that this occurs locally for the 
long-term synaptic plasticity underlying memory formation (Tom Dieck et al., 2014 and 
Santini et al., 2014). These results together with others reported in the literature lead 
us to the next question. How is DBN translation controlled in neurons and where are 
DBN transcripts localized? Therefore, it became relevant to study whether DBN is 
synthesized locally or if it is transported to the dendrites. To address these questions, 
I made use of two technologies. Firstly, I applied metabolic labeling with puromycin in 
combination with PLA (Puro-PLA) for the investigation of DBN translation control. 
These experiments are described in section 2.2.4.1.   And secondly, I performed high-
resolution fluorescence in situ hybridization (FISH) for the visualization of DBN mRNA 
transcripts as shown in section 3.     
 
2.2.4.1 Visualization of in situ DBN translation in neurons applying metabolic 
labeling with puromycin in combination of the proximity ligation assay.  
Puromycin is an antibiotic that acts as a protein synthesis inhibitor by truncating the 
nascent chain of a peptide. It is also structurally an aminoacyl tRNAs analog (see 
Figure 24) and can be used for metabolic labeling of translated proteins. It has been 
used successfully as a nonradioactive method to measure protein synthesis rates  
(Schmidt et al., 2009), as well as to visualize de novo proteins in situ in combination of 
PLA as reported in and named Puro-PLA (Tom Dieck et al., 2015). 




Figure 24| Metabolic labeling with puromycin. A) Chemical structures of the amino acid 
tyrosine, the tRNA Tyrosyl and the protein synthesis inhibitor puromycin. Puromycin is a tRNA 
analog and can covalently bind into nascent peptide chains. B) Schematic representation of 
the process of protein synthesis in the presence of puromycin which inhibits the process of 
synthesis inducing the release of the synthesized peptide when binding to the nascent chain.  
(Figure adapted from Goodman and Hornberger (2015). 
In addition to studying the turnover of DBN in neurons, I also explored the localization 
of newly synthesized DBN. To do so, I visualized newly synthesized DBN combining 
puromycilation applying Puro-PLA in neurons.  
For this, cells are briefly treated with puromycin to label proteins in the process of 
translation, then PLA for DBN and puromycin is performed. Finally, microscopy 
imaging is used to capture multiple images for the analyses of PLA (see Figure 25 for 
diagram). The resulting signal provides a quantitative read-out for DBN synthesis rates 
as well a quantitative result for the localization of the protein synthesis in the cell.  




Figure 25| Puro-PLA. N1E cells or primary mouse neurons are treated with different inhibitors 
for 1 h followed by a 3 min incubation with 1 µM puromycin with or without the respective 
inhibitors. Cells are fixed and PLA with antibodies against puromycin and DBN is performed.  
These experiments demonstrate than a pool of DBN is translated in dendrites and 
spines, implying that DBN is locally translated in dendritic shafts. This can be observed 
in the upper panel of Figure 26. The arrow indicates de novo synthesized DBN puncta 
found in dendrites. This observation is in line with the previously shown distribution of 
DBN detected in neurons when applying FUNCAT-PLA (see Figure 22). In contrast to 
FUNCAT-PLA where pulse-labeling with AHA was performed for 2 h, allowing enough 
time for protein transport, in Puro-PLA the pulses with Puro were performed for only 3 
min, excluding long-range protein transport. However, short-range protein diffusion 
cannot be completely excluded during the delay between labelling and fixation. 
Nevertheless, to further confirm this observation I explored the localization of DBN 
transcripts in neurons as shown in the last section of results. 
To evaluate the specificity of the labeling, two negative controls for the Puro-PLA assay 
were included: anisomycin to block protein synthesis with a pre-treatment of 30 min 
and a condition without puromycin. As shown in Figure 26 , no signal comparable to 
the control can be detected, proving the specificity of the antibodies in this assay and 
the specificity of the puromycin labeling.  




Figure 26| DBN is locally synthesized. Cultured hippocampal neurons from E16.5 mice were 
grown for 14 DIV and incubated for 3 min with 1 µM puromycin, washed and fixed. PLA with 
antibodies against puromycin and DBN was then performed on the fixed cells. Puromycin 
(puro) shows DBN synthesis in situ and anisomycin (aniso + puro) or No puromycin (no puro) 
are negative controls. Arrows in top right image indicate PLA signal found in distal dendrites. 
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2.2.4.2 DBN protein synthesis is affected by the PI3K-mTOR pathway 
One of the main objectives of this thesis was to find regulatory inputs for the turnover 
of DBN. Therefore, I wanted to explore whether the Phosphatidylinositol 3-kinase – 
mammalian target of rapamycin (PI3K-mTOR) pathway (see Figure 27 for schematic 
representation) plays a role in the regulation of DBN translation. The PI3K-mTOR 
pathway is known to control the translation of some proteins, therefore we explored 
whether DBN was one of those.   
The PI3K pathway controls essential processes of the cell such as cell proliferation 
and cell growth. PTEN antagonizes this pathway while PI3K activates it. In neurons, 
the kinase activity of mTOR is involved in translation regulation and long-lasting 
synaptic plasticity. The PI3K pathway starts with the activation of PI3 kinase which 
occurs after growth factor stimulation. Phosphoinositol-3-Kinase (PI3K) catalyzes the 
conversion of phosphatidylinositol 4-5 diphosphate (PIP2) into phosphatidylinositol 
3,4,5 triphosphate (PIP3). This reaction is antagonized by phosphatase and tensin 
homolog (PTEN). PIP3 activates Protein kinase B (AKT) which subsequently can 
activate the mammalian target of rapamycin (mTOR). mTOR activates ribosomal 
protein S6 kinase beta-1 (S6K1), this activation has an effect in protein synthesis. 
4EBP, in contrast, if activated has a translation repression activity. A schematic 
representation of a simplified version of this pathway as well as the target proteins for 
some inhibitors of the pathway are shown in Figure 27.  




Figure 27| Simplified schematic representation of the PI3K-mTOR pathway. Phosphoinositol-
3-Kinase (PI3K), Protein kinase B (AKT), phosphatase and tensin homolog (PTEN) 
mammalian target of rapamycin (mTOR), ribosomal protein S6 kinase beta-1 (S6K1). Inhibitors 
for PI3K, PTEN and mTOR are indicated in the pathway.  
In order to gain insights into the regulation of DBN translation in dependence of the 
PI3K-mTOR pathway, I first tested the mTOR inhibitor rapamycin, the PI3K inhibitor 
GDC0941 and the PTEN inhibitor bpV(hopic) in cells and analyzed their activity by 
western blotting (Figure 28). Inhibition of mTOR with rapamycin resulted in the 
reduction of downstream pS6 levels, inhibition of PI3K decreased the levels of 
pS473AKT and inhibition of PTEN with increased pS6 levels. These results proved that 
all inhibitors were working and acting as anticipated in this cellular model.  




Figure 28| Different inhibitors induce inhibition or over-activation of the PI3K-mTOR pathway. 
N1E cells were treated for 1 h with 100 nM rapamycin, 0.25 µM GDC0941, 100 nM or 1 µM 
bpV (hopic) in duplicates or DMSO as a control. Cell lysates were collected and analyzed by 
western blotting to evaluate the inhibitors activity using AKT-pS473, pS6 and α-actin as a 
loading control.   
The next step was to control for the efficiency of puromycin in western blot and to 
confirm that the presence of puromycin does not affect the activity of the tested 
inhibitors. To do so, puromycilation for 5 min was analyzed by western blotting. A 
schematic representation of the experimental design is depicted in Figure 29. 
 
 
Figure 29| Puromycilation protocol. A) N1E cells are treated with different inhibitors for 1 h 
followed by a 5 min incubation with 4 µM puromycin with or without the respective inhibitors. 
Cells are lysed and lysates are analyzed by western blotting. To detect puromycilation a 
puromycin antibody is applied in Western blots.    
Results on Figure 30-A show a reduction on pS6 upon treatments with rapamycin, an 
increase in pS6 after PTEN inhibition and a reduction of pS473 after PI3K inhibition. 
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These results prove that co-treatment with puromycin does not interfere with the 
activity of the applied inhibitors. In parallel, in Figure 30-B, it can be observed that 
puromycin efficiently labeled newly synthesized proteins and that this labeling can be 
completely abolished with a pre-treatment with anisomycin (aniso) to block protein 
synthesis. Additionally, absence of puromycin (no-puro) does not provide any signal, 
confirming the specificity and efficiency of the labeling of de novo synthesized proteins 
in N1E cells without detectable background. 
 
Figure 30| Controls for PI3K-mTOR pathway inhibitors in combination of puromycin. A) In 
order to confirm that our different inhibitors are active in combination of puromycin, N1E cells 
were grown in DMEM 1 % FCS for 24 h and then treated for 1 h with 40 µM anisomycin, 100 
nM rapamycin, 0.25 µM GDC0941,100 nM or 1 µM bpV (hopic), or  DMSO as a control and 
directly incubated for 5 min with 4 µM Puromycin +/- inhibitors. Cells were washed with PBS 
and cell lysates were collected and analysed by western blotting to evaluate the activity of the 
inhibitors in the presence of puromycin; a tRNA analog that causes protein truncation, probing 
for AKT-pS473, pS6 and α-actin as a loading control. In line with what is reported in the 
literature, pS6 levels are massively reduced when rapamycin is applied and in contrast 
increased when PTEN is inhibited with bpV, pS473AKT levels are downregulated when PI3K 
inhibitor GDC0941 is applied and anisomycin blocks protein synthesis. B) Samples were 
analyzed using a Puromycin antibody to detect the total newly synthesized proteins or the 
puromycilated fraction and α-actin as a loading control. Importantly, the respective inhibitors 
do not seem to affect global protein synthesis while we observe that some of them affect DBN 
protein synthesis specifically in our Puro-PLA experiments.    
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To further investigate the potential role of the PI3K-mTOR pathway in the regulation of 
DBN translation, I performed PURO-PLA experiments in combination with acute 
inhibitions of PTEN, PI3K or mTOR. Quantification of the PLA signal for all the different 
conditions proves that the inhibition of PTEN and PI3K do not affect the translation rate 
of DBN in comparison to the control. However, inhibition of mTOR significantly reduces 
DBN synthesis in N1E cells. These results are shown in Figure 31.  
  
Figure 31| Treatment with rapamycin reduces DBN translation. A) N1E cells were grown in 
DMEM 1% FCS for 24 h and then treated for 1 h with 100 nM rapamycin, 0.25 µM 
GDC0941,100 nM or 1 µM bpV (hopic), 4 µM anisomycin, or  DMSO as a control and directly 
incubated for 3 min with 1 µM Puromycin +/- inhibitors or without puromycin. Cells were 
washed and directly fixed. PLA with antibodies against puromycin and DBN was then 
performed on the fixed cells. B) DBN Puro-PLA quantification. (Error bars indicate SEM of 
three independent experiments and * pValue< 0.01). Scale bar: 10 µm. 
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2.3 Visualization of DBN mRNA in neurons and abundance upon neuronal 
stimulation 
 
2.3.1 DBN mRNA transcripts are present in dendrites.  
Experiment performed in neurons applying FUNCAT-PLA and Puro-PLA show that de 
novo synthesized DBN is present in dendrites and spines. This observation suggested 
that DBN could be a protein which local translation is needed during synaptic plasticity. 
To further characterize the localization of DBN translation I performed high-resolution 
FISH experiments for the visualization of DBN transcripts in neurons. Confocal 
microscopy images of these experiments show the presence of DBN mRNA in 
dendrites supporting the idea that DBN translation is localized (Figure 32). A negative 
control where no probe was added was included in the experiment and as shown in 
Figure 32 no signal can be detected. 
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Figure 32| DBN transcripts are localized in dendrites. A) Schematic representation for the in 
situ hybridization amplification system for the fluorescence detection of mRNA (Panomics). B) 
RNA fluorescence in situ hybridization for DBN mRNA using Panomics probes. MAP2 staining 
was applied as a neuronal marker and DAPI as nuclear stain. Images were modified for 
visualization purposes. Scale bar: 20 µm 
 
2.3.2 Visualization of DBN mRNA abundance in neurons with high-resolution FISH  
Cajigas et al. 2012 reported over 2000 mRNAs to be present in the neuropil, including 
DBN. In addition, high-resolution FISH in cultured hippocampal neurons clearly 
showed the presence of diverse mRNA transcripts in dendrites and also different soma 
to dendrite ratios for the abundance of these (Cajigas et al., 2012). Therefore, I 
performed high-resolution FISH for DBN, beta-actin and CamKII. By observing 
representative images it is possible to compare their abundances in cultured neurons. 
CamKII is reported to be highly abundant in neurons, this can also be observed in my 
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experiments. When comparing these levels those of Beta-actin and DBN mRNA 
puncta it looks like they are in the lower range (Figure 33). However, more experiments 
should be performed for a clear conclusion on this matter.   
 
 
Figure 33| DBN, CamKII and Beta-actin mRNA abundance in neurons. RNA fluorescence in 
situ hybridization for detection of DBN mRNA (A), CamKII mRNA (B) and Beta-actin mRNA 
(C) was performed in primary hippocampal neurons using Panomics probes. MAP2 staining 
was applied as a neuronal marker and Dapi as a nuclear staining. Representative images show 
different transcript abundance for DBN and Beta-actin in comparison to CamKII known to be 
highly abundant in neurons.  
 
2.3.3 Neuronal network silencing during homeostatic plasticity results in more DBN 
localized transcripts. 
In order to investigate whether DBN is regulated at the transcriptional level upon 
synaptic activity stimulation or during homeostatic plasticity, I performed high-
resolution FISH in cultured hippocampal neurons after treating 24-28 DIV neurons for 
2 h with either bicuculline, TTX + APV or vehicle control. Using the PLA plugin for FIJI 
I quantified the total signal (Figure 34 -B), the signal in the soma (Figure 34-C) and 
calculated the signal in the periphery (Figure 34-D) for the different conditions. The 
results are shown in Figure 34. No significant differences are observed after enhancing 
synaptic activity with biccuculline in comparison with the control. However, silencing of 
the network and spontaneous activities with TTX + APV changes the total mRNA 
abundance of DBN. No changes are observed in the soma whereas an increase in the 
abundance in dendrites is evident. 






Figure 34|Neuronal network silencing results in more DBN transcripts. A) RNA fluorescence 
in situ hybridization for DBN mRNA using Panomics probes was performed in primary 
hippocampal neurons treated for 2 h with Bicuculline (30 µM), TTX (1µM) + APV (20 µM) or 
vehicle control. MAP2 staining was applied as a neuronal marker and DAPI as a nuclear stain. 
Images were modified for visualization purposes. B) Global mRNA signal was quantified after 
MAP2 normalization as percentage of Vehicle-control C) Signal in somata and D) Signal in 
dendrites.  




Experimental evidence in neurons for DBN overexpression (Kreis et al., 2013; Mizui et 
al., 2005), DBN downregulation (Takahashi et al., 2006) and complete depletion of 
DBN in a DBN-KO model (Jung et al., 2015) have shown that DBN levels - too high or 
too low - can affect spine morphology as well as synaptic function. These results 
suggested that DBN abundance is essential for the modulation and stability of spine 
morphology. Moreover loss of DBN in the brain is linked to cognitive impairment as 
well as Alzheimer’s disease and Down’s syndrome. Therefore, studying the inputs that 
control the turnover and stability of DBN is of great interest not only to understand how 
DBN is regulated but also to understand how DBN affects synaptic plasticity and how 
it contributes to aging.  
Protein damage and oxidative stress are thought to contribute to age-related 
pathology. Thus, in the first section of my discussion I analyze the decrease of DBN 
abundance during oxidative stress conditions using oxidizing agents in neurons. The 
second part of the discussion is dedicated to understanding how DBN stability is 
regulated and how DBN is degraded.  
In the last two sections I will discuss the regulation of DBN translation and the presence 
of DBN transcripts in dendrites.  
3.1 Effect of oxidative stress on DBN abundance and its link to 
neurodegeneration 
 
During aging, the entire proteome is affected by oxidative stress, however the 
consequences may differ from one protein to another. Considering the decrease of 
DBN during aging, I hypothesized that DBN may be modified by oxidative stress. To 
assess DBN stability during oxidative stress, I challenged matured cortical neurons 
with H2O2 and Paraquat, compounds that are commonly used to induce oxidative 
stress (Wang et al., 2009; Doré et al., 1999; Ramalingam and Kim, 2011) as well as 
Aβ the Alzheimer’s disease related protein. In order to find the right experimental 
conditions, H2O2, Paraquat and Aβ were tested at different concentrations and applied 
in cultured cortical neurons. I observed that H2O2 at the tested concentrations has no 
effect on DBN protein levels at 14 DIV cortical neurons. Treatments with Aβ were 
difficult to reproduce since occasionally the effect was very toxic leading to neuronal 
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death.  However, the herbicide paraquat reduced DBN protein levels in a 15 µM 
concentration with no cytotoxic effects, providing a good platform for future 
experiments targeting the regulation of DBN abundance during oxidative stress   
Towards finding new therapeutics for the treatment of neurodegenerative diseases 
where neuronal loss occurs, studying the effect of reactive oxygen species during 
synaptic plasticity is a very common approach (Guo et al., 2015; Santini et al., 2015). 
Moreover, oxidative stress has been described as one characteristic in 
neurodegeneration (Klein and Ackerman, 2003). Therefore, having an experimental 
system where DBN protein levels decrease is an important readout in the context of 
neurodegeneration. Future studies, could clarify the molecular mechanisms behind 
DBN and its described downregulation in AD (Counts et al., 2012; Harigaya and Shoji, 
1996) and Down syndrome (Shim and Lubec, 2002).   
Overall, these results provide insights into the potential regulation of DBN abundance 
during oxidative stress. However, to clarify the mechanisms modulating the effects on 
DBN decreasing levels, further investigation is necessary. 
3.2 DBN turnover and stability in dependence of S647 phosphorylation 
 
We have previously shown that DBN interacts with the phosphatase and tensin 
homolog (PTEN) protein. We found that DBN is highly phosphorylated at Serine 647 
residue and that this phosphorylation is negatively regulated by the phosphatase PTEN 
(Kreis et al., 2013). A reduction in PTEN protein levels coincided with an increased in 
pS647-DBN levels (Kreis et al., 2013). Moreover, the PTEN-DBN interaction is 
destabilized upon neuronal activity. Therefore, we were interested in the understanding 
of the dynamics of DBN phosphorylation and dephosphorylation and its role in DBN 
stability during synaptic plasticity.  
My PhD thesis had as one key objective to answer how DBN abundance is regulated. 
To address this question, I studied DBN turnover in pulse-chase experiments in 
HEK293T cells. These experiments suggest that DBN is a long lived protein with an 
estimated half-live of 3 days. Moreover I was able to show that the stability of DBN is 
controlled by the phosphorylation of the S647, located at the C-terminus of the protein 
and that the turnover of DBN is slower when inhibiting the UPS. To further confirm 
these results, I searched for an experimental approach that could allow me studying 
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DBN turnover at the endogenous level in neurons. I applied FUNCAT-PLA in cultured 
hippocampal neurons and followed the degradation profile of endogenous DBN for 24 
and 68 h after pulse labeling with AHA. Analyses of these experiments confirmed that 
DBN is a long lived protein in neurons with a calculated half-life of ~ 70 h. This is in 
line with my previous experiments using biochemical pulse chase assays, which 
indicated the half-life of DBN to be ~ 75 h. Moreover, Cohen and colleagues have 
estimated the protein half-life of 150.48 h for DBN and suggested that the average 
turnover of synaptic proteins is of 99.6 h (Cohen et al., 2013). In contrast to my 
experimental approach for DBN turnover analysis, Cohen et.al, (2013) calculated 
protein half-lives mass spectrometry analyses. The analyzed data was generated by 
applying isotope labeling with amino acids in cell culture (SILAC) in 14 DIV rat cortical 
neurons,  while our data was obtained from the analyses of  HEK293T cells and 18-21 
DIV rat hippocampal neurons labeled with AHA. Different cell systems as well as 
different techniques for labeling proteins could be the reason for finding a big difference 
between the calculated half-life for DBN by Cohen et.al. (2013) (~150 h) and the half-
lives I calculated in both my assays (~ 75 h). Nevertheless, in both cases DBN results 
to be a long-lived protein.  
Overall, my data provides new information on the turnover of DBN and confirms that 
DBN is a very stable protein which stability is controlled by phosphorylation.   
 
3.3 DBN stabilization upon inhibition of the ubiquitin proteasome system  
 
In order to study the possibility of DBN stabilization when inhibiting the most common 
path of degradation in the cell I applied MG132, an UPS inhibitor in my pulse-chase 
experiments. There was no data available in the literature concerning the mechanisms 
for DBN degradation. Our first hypothesis was that DBN could be ubiquitinated and 
degraded via the UPS. To address this, I performed pulse-chase experiments in 
HEK293T cells as shown in the result section (Figure 19) in the presence or absence 
of MG132, an UPS inhibitor. The addition of MG132 during the chase resulted in the 
stabilization of DBN, suggesting that DBN degradation could be directed by 
ubiquitination. To study this further, ubiquitination experiments (not shown in this 
thesis) were performed by Dr. Patricia Kreis. The results support the observation of 
DBN degradation by UPS. However, in 2015, Yoshida and colleagues reported DBN 
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degradation by calpain. In this work, they induced excitotoxicity in cultured 
hippocampal neurons by prolonged stimulation of NMDA-receptors (NMDA-R) 
(Chimura et al., 2015). Excitotoxicity is the pathological term for neuronal degeneration 
by long exposures to neurotransmitters or excessive depolarization of the cells.  Such 
stimulation induced the degradation of DBN after only a few hours when treated acutely 
with NMDA. The NMDR-R overstimulation induced degradation of DBN was rescued 
when applying a chelating agent or a calpain inhibitor suggesting DBN degradation by 
calpain (Chimura et al., 2015).  
Two ways of degradation for DBN are presented here. DBN degradation by calpain is 
suggested to occur by NMDA induced excitotoxicity in neurons while inhibition of the 
UPS with MG132 stabilizes DBN in pulse-chase experiments. Further investigation 
would be needed to clarify how exactly DBN degradation is targeted and whether 
different conditions activate different pathways for the degradation of the protein. 
Specific degradation of proteins can be context dependent regulated. This is the case 
for exampled for PTEN. PTEN has been described to be ubiquitinated and degraded 
by the UPS (Lee et al., 2015) in cancer cell lines. However it has also been suggested 
that PTEN degradation is mediated by calpain-2 after neuronal stimulation with BDNF 
(Briz et al., 2013). This example, supports the idea that DBN degradation can be 
controlled by different mechanisms during different responses.  
3.4 Regulation of DBN translation by the PI3K-mTOR pathway  
 
Protein turnover is the result of protein synthesis and protein degradation. In order to 
get insights into the regulation of DBN turnover I first addressed DBN degradation in 
dependence of phosphorylation as discussed in previous sections. However, it was 
important to explore potential regulators of DBN translation. Therefore, as a first 
approach I targeted several candidates of the PI3K-mTOR pathway, a pathway known 
to regulate protein synthesis. The mammalian target of rapamycin (mTOR) is an 
evolutionary conserved kinase known to play a role in controlling protein synthesis 
during synaptic plasticity and memory (Blenis, 2009; Santini et al., 2014).  There are 
multiple stimuli controlling mTOR activity in neurons. Neurotransmitters and metabolic 
changes can activate mTOR through upstream activation of AMPA-receptors, NMDA-
receptors, dopamine receptors, mGluRs and BDNF receptors. It has been suggested 
that mTOR signaling contributes to short-term (minutes) and long term (hours) 
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activation of translation. De novo protein synthesis that occurs after neuronal 
stimulation has been observed to happen locally in the active synapses providing 
evidence to the idea that localized translation is associated and needed for memory 
formation during synaptic plasticity (Costa-Mattioli et al., 2009; Santini et al., 2014). 
In order to elucidate signaling mechanisms responsible for DBN regulation as well as 
what events during synaptic plasticity induce or block DBN synthesis or degradation, I 
studied DBN synthesis in the presence of PI3K, mTOR and PTEN inhibitors applying 
PURO-PLA in N1E cells. The results show that DBN translation is controlled by mTOR 
since inhibition of mTOR with rapamycin decreased DBN translation rates.  
It is well known that the mTOR signaling pathway is essential for synaptic plasticity and 
memory consolidation. The evidence indicates that late long-term potentiation (L-LTP 
induces the phosphorylation of mTOR downstream proteins. Moreover, application of 
rapamycin inhibits long-lasting synaptic changes and memory formation in mammals 
during certain behavioral tasks (reviewed in Costa-Mattioli et al., 2009).  
My results together with the literature lead to the hypothesis that DBN translation during 
L-LTP, which underlies synaptic plasticity and mimics memory, may be regulated by 
mTOR downstream targets. In order to study whether DBN translation is controlled by 
mTOR during synaptic plasticity, examination of DBN translation upon short treatments 
with rapamycin during L-LTP in neurons would clarify this point. This could be 
performed applying PURO-PLA in neurons combining BDNF and Rapamycin 
treatments.    
3.5 DBN localized translation in dendrites 
 
Applying FUNCAT-PLA in neurons I have been able to visualize the pool of DBN 
protein that is synthesized within two hours in neurons. Newly synthesized DBN is 
enriched in the dendritic shaft and localizes at the base of the spines. Whether DBN 
was locally translated or transported after synthesis remained an open question after 
performance of the pulse-chase experiments with AHA where the pulse lasted 2 h, 
enough time for protein transport to occur. However, application of PURO-PLA 
demonstrates that a pool of DBN is translated in dendrites supporting the idea that 
DBN is locally translated in neurons. This observation may emphasize the role of DBN 
in synapse maintenance. It has become clear that in neurons several synaptic proteins 
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are locally translated in dendrites and synapses (Tom Dieck et al., 2014). 
Polyribosomes have been identified in the dendritic shafts and spines, which 
suggested a role of local protein synthesis in the regulation of synapses (Ostroff et al., 
2002) Furthermore, it has been proposed that synaptic plasticity requires synthesis of 
proteins and that this occurs locally during long-lasting synaptic plasticity; underlying 
memory formation (Costa-Mattioli et al., 2009; Kang et al., 1996; Santini et al., 2014; 
Tom Dieck et al., 2014). In order to further characterize the regulation of localized DBN 
translation in dendritic shaft other experiments need to be performed. For example 
induction of neuronal stimulation by applying BNDF together with rapamycin, shown to 
control DBN translation in my experiments with N1E cells, could provide interesting 
data. Nevertheless, the general consensus indicates that late phase of LTP depends 
on transcription since it has been shown to be blocked when applying inhibitors for 
transcription and for translation (Costa-Mattioli et al., 2009).  
3.6 Dendritic localization of DBN mRNA  
 
My data generated with FUNCAT-PLA and PURO-PLA suggests that DBN is locally 
translated in neurons. However, to further support this observation I examined the 
localization of DBN transcripts in neurons. Interestingly, I found DBN transcripts in the 
dendrites of cultured hippocampal neurons. This observation was performed by 
applying high-resolution in situ hybridization. DBN is not the first transcript to be found 
in dendrites, in fact several mRNAs have been shown to be transported into dendrites 
in cultured hippocampal neurons (reviewed by Martin and Zukin, 2006). Some of the 
first mRNAs that were identified to be localized in dendrites include the microtubule 
associated protein MAP2 (Garner et al., 1988), the activity-regulated cytoskeleton-
associated proteins Arc (Lyford et al., 1995) and the brain-derived neurotrophic factor 
BDNF (Tongiorgi et al., 1997). However, more recently applying deep sequencing 
analyses and high-resolution in situ hybridization, Schuman and colleagues generated 
a library with more than 2000 transcripts identified in the neuropil of the hippocampus 
(Cajigas et al., 2012). In this study DBN was identified as one of the localized mRNAs 
in dendrites. However, I am the first to show the visualization of localized DBN mRNAs 
in the dendrites of cultured hippocampal neurons. 
Localized transcripts are transported into dendrites in large granules where they 
remain latent until activation by specific stimuli. The granules contain mRNAs, RNA 
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binding proteins, ribosomes and translational factors. The mRNA trafficking is a quick 
process with an average speed of 0.1 µm/s, is bidirectional and it is directed by 
microtubules (reviewed by Martin and Zukin, 2006).  
Dendritic mRNA localization has been described to play a role in neuronal development 
and synaptic plasticity. Moreover, several studies have reported examples for dendritic 
mRNAs pools which turnover or show trafficking changes upon neuronal stimulation. 
Tongiorgi et.al. (1997) demonstrated that the dendritic localization of mRNAs coding 
for BDNF and its receptor TrkB increases after neuronal stimulation with high 
potassium (Tongiorgi et al., 1997).  
Towards finding potential inputs regulating DBN mRNA trafficking into dendrites, I 
applied biccuculline to enhance synaptic activity and Tetrodoxin (TTX) together with 
APV to silence the neuronal network onto cultured neurons. Use of both TTX and APV 
results in complete blockage of synaptic activity. TTX blocks neurotransmitter release 
by action potentials and APV, an NMDA antagonist, inhibits miniature excitatory 
synaptic events. Application of bicuculline had no effect on DBN mRNA abundance or 
localization. However, after simultaneous application of TTX and APV in cultured 
hippocampal neurons I observe an increase in the total abundance of DBN transcripts 
and this increase is observed to be significantly different in the dendrites but not in the 
soma in comparison to the vehicle-control, after the inhibition of active and 
spontaneous synaptic events. One possible explanation for this, is that this kind of 
stimulation induces both transcription and trafficking of DBN transcripts into dendrites. 
However, to fully understand what the reason for this change in the dendritic DBN 
mRNA pool is, other experiments need to be performed. In general, changes in the 
abundance and localization of DBN transcripts could be due to an increase in mRNA 
synthesis (1), changes in the turnover of DBN mRNA (2) or due to unmasking of mRNA 
granules (3) permitting the targeting of the transcripts and their visualization. 
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4 Conclusions and Outlook  
Changes in dendritic spine morphology alter synaptic activity and plasticity, a 
phenomena important in memory formation, ageing and disorders such as mental 
retardation. One key protein in these processes is DBN, which is fundamentally 
important in regulating dendritic spine morphology. During my PhD, I studied the effect 
of site-specific phosphorylation of DBN and found that this post-translational 
modification regulates protein stability and turnover. In this context, my work identifies 
that DBN is locally translated in the dendritic spines in cultured hippocampal neurons.  
 
The overall aim of my PhD project was to understand regulatory inputs relevant to the 
protein abundance of DBN. DBN abundance declines with age and this is correlated 
with cognitive decline during ageing. I have identified a phosphorylation site (S647) 
controlling DBN stability and found that oxidative stress induced by treatments with the 
herbicide paraquat reduce DBN protein levels in neurons in a concentration dependent 
manner.  
 
During my PhD work, I also investigated the control of DBN synthesis. This was 
assessed with the PURO-PLA assay by application of different PI3K and mTOR 
inhibitors in neurons and N1E-115 cells. I could demonstrate that DBN translation is 
regulated by mTOR pathway. These results are very interesting since rapamycin is 
known to block long term synaptic plasticity and L-LTP is known to involve the 
transcription and synthesis of new proteins in dendrites and synapses. Performing 
experiments in neurons during L-LTP and simultaneously adding rapamycin could 
provide new information clarifying the mechanisms behind DBN turnover in neurons 
and its role in the modulation of spine maintenance.  
Furthermore, my experiments for the visualization of DBN mRNA in neurons 
demonstrate their dendritic localization. Treatments in neurons for the blockage of 
synaptic activity with TTX and APV resulted in an increase in the dendritic localization 
and abundance of DBN mRNA. These results indicate that local translation of DBN 
might be indirectly regulated by spontaneous activity.  
Overall my work provides new insights into the regulation of DBN turnover and stability. 
In addition, I show that DBN translation is controlled by mTOR and my data also 
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suggests that DBN degradation occurs via the UPS. This thesis also delivers data 
demonstrating the dendritic localization of both DBN transcripts and DBN translation.  
A working model summarizes all these findings and postulates that DBN turnover in 
neurons is locally controlled. Several inputs mentioned previously contribute towards 
the regulation of DBN turnover and are shown in Figure 35. However, further work 
needs to be performed to better correlate DBN protein abundance with synaptic 
function, spine maintenance and synaptic plasticity.  
 
 
Figure 35| Working model for the control and regulation of DBN turnover in dendritic spines. 
This thesis show that DBN translation is controlled by mTOR pathway. Data in this thesis 
suggest that DBN mRNA trafficking and transcription are indirectly regulated by spontaneous 
synaptic activity. On the other hand, DBN stability dependent of phosphorylation of S647, and 
as shown before in the Eickholt Lab PTEN depletion increases pS647-DBN levels therefore 
indirectly regulating DBN turnover in a PI3K-independent manner. Last, this thesis shows that 
DBN translation occurs locally in dendrites and in proximity of the spines. We propose that 
DBN turnover is controlled locally in spines and that this regulation contributes to synaptic 
function, spine maintenance and synaptic plasticity.   
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5 Materials and Methods 
This chapter explains how the experimental work was conducted. It should enable the 
reader to fully understand the results reported in Chapter 3.  It provides all the 
necessary details for successful replication. All experimental techniques used, as well 
as the preparation of the experimental samples, are covered. 
This chapter is organized as follows: Sections 5.1 to 5.10 contain the lists of laboratory 
consumables, protocols and detailed information used in the realization of the 
experimental work presented in this thesis. The topics include: experimental models, 
treatments and manipulations, assays, imaging-acquisition, molecular biology, 
solutions and buffers, culture medium and chemicals and kits.   
1.1 Molecular biology 
Transfections in this work were performed using lipofectamine and the following 
plasmids were available in the Eickholt Lab. All these constructs have the CMV 
promoter. All YFP- and Flag-DBN constructs were generated in the Eickholt lab and 
are based on the human cDNA sequence. DBN constructs with serine to 
alanine/aspartic acid substitutions were generated by site directed mutagenesis, and 
then validated by sequencing. The Myc-DBN E construct originated from the lab of T. 
Shirao (Gunma University, Japan). 
1.1.1 Plasmids 
YFP-DBNA, YFP-DBNE, YFP-DBNAS647A, YFP-DBNAS647D, YFP-DBNES601A, 
YFP-DBNES601D, YFP-empty, Flag-DBNE, Flag-DBNES601A, Flag-DBNES601D, 
Flag-empty and Myc-DBNE. 
1.2 Consumables 
 
All consumables are enlisted in five tables presented in this section.  
Table 1: Primary antibodies 
Table 2: Secondary antibodies and HRP-reagents 
Table 3: Buffers 
Table 4: Culture medium  
Table 5: Chemicals and kits  




Table 1 lists the primary antibodies, the assays in which they were applied, and their 
dilutions. Company and catalog number are indicated to facilitate their acquisition 
when commercially available.  
Table 1- Primary antibodies 
Antibody name Antibody 
specie 
Assay Dilution Company Catalog.No 
Debrin M2F6 mouse FUNCAT-PLA 
WB 











Dr. Till Mack) 
DBN Guinea pig WB 1:1000 Progen GP823 







Biotin rabbit PLA 1:5000 Cell signaling 5597 
Biotin mouse PLA  Sigma-
Aldrich 
B7653 
PTEN (138G6) rabbit WB 
PLA 
1:100 Cell signaling 9559 
pS6 (Ser235/236) rabbit WB 1:1000 Cell signaling 2211 
P44/42 MAPK 
(Erk1/2) 





















MAP2 guinea pig Immuno. 1:1000 Synaptic 
Systems 
188004 
Alpha-Tubulin mouse WB 1:3000 SRM T6199-200UL 








GAPDH [6C5] mouse  1:5000 Calbiochem CB1001 
Tubulin [YL1/2] rat immuno 1:500 Abcam ab6160 
anti-Ubiquitin rabbit  1:1000 DAKO 00051128) 
pAKT(Ser 473) rabbit WB 1:2000 Cell signaling 4060L 
 
AKT (pan) rabbit WB 1:2000 Cell signaling 4691 
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Table 2 lists the secondary antibodies, assays in which they were applied, and the 
corresponding dilutions. Company name and catalog number are indicated to facilitate 
their acquisition when commercially available.  
 
Table 2- Secondary antibodies and HRP-reagents 
Antibody name Assay Dilution Company Catalog.No 
Streptavidin-HRP WB 1:500 Cell signaling  
Anti-mouse WB 1:3000 VECTOR PI-2000 
Anti-rabbit WB  VECTOR PI-1000 
Anti-mouse alexa 
568 
Immuno 1:500 Invitrogen A-11004 
Anti-mouse alexa 
488 







Immuno 1:500 Invitrogen A-11011 
Anti-rabbit alexa 
488 





Anti-rat alexa 568 Immuno 1:500 Invitrogen A-11077 
Anti-guinea pig 
Cy5 





guinea pig IgG 
Cy2                   
 





Alexa Fluor 488 
phalloidin 











1.3 Solutions and buffers 
Table 3 lists the name and recipes of buffers and solutions prepared and used for 
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Table 3- Buffers  
Buffer name Concentration Assay Chemicals Company Catalog.No. 
Buffer A 
Buffer B 

















10 mg/ml in 
HBSS 








50 mM Tris-HCl  
150 mM NaCl  
0.05% Tween 20 
detergent  


















Ready made WB  Roth K929.2 
 








Ready made WB  AppliChem A7140, 0125 
 






HCL pH 7.4 












PBS 1x Tablets for 
preparation of 500 
ml PBS in water  








5% Milk in TBS-T WB Low fat 
powder milk 
Roth  T145.2 
 
Mowiol 4-88  
 
5 g Mowiol 
20 ml PBS 
10 ml glycerine 
Immuno  Calbiochem  
PBS-MC 1 x PBS PH 7.4 
1mM MgCl2 
(Stock: 1M in 
H2O) 
0,1mM CaCl2 












20 g PFA 
400 mL PBS-MC 
5 µl MgCl2- Stock 
(1M in H2O) 
5 µl CaCl2- Stock 
(0,1M in H2O) 




   
Poly-DL-
Ornithine 
1.5-mg/mL (100X)    Sigma 
Aldrich 
P8638 




1.4 Culture medium 
 
Table 4 lists the different medium cultures used for growing the cell lines and primary 
neurons.  
Table 4- Culture medium 
Medium Cell type Company 
DMEM + GlutaMax Cell lines Gibco – 31966021 
MEM Glial cells (rat) Gibco – 31095029 
Neurobasal-A Primary cultures Gibco- 10888022 
DMEM Met-Free 
(custom made) 
293T cells for metabolic 
labeling 
Gibco 
Neurobasal-A Met- free 
(custom made) 
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1.5 Chemicals and kits 
 
Table 5 shows the list of chemicals and kits used during this project. 
 
Table 5- Chemicals and kits 
Chemical Assay Company Catalog.No. 










FUNCAT-PLA Jena Biosciene 
GmbH 
CLK-TA105 
ECL western blotting 
substrate 
WB Promega REF W1001 
CuSO4-5H2O FUNCAT-PLA Sigma-Aldrich 678937 
TCEP-HCl FUNCAT-PLA Pierce 20490 
Triazole ligand 
(TBTA) 
FUNCAT-PLA Sigma-Aldrich 678937 







Reaction Buffer Kit 
Click-chemistry (cell lysates) Invitrogen C10276 
Hoechst IC Sigma-Aldrich 14530 
Biotin-alkyne  
(4 mM stock) 
Click-chemistry (cell lysates) Invitrogen B10185 
protease inhibitor 
cocktail 










inhibitor cocktails 2 
and 3 
WB Sigma-Aldrich P5726 and P0044 
Rapamycin mTor inhibitor, 
puromycilation 
Cell signaling 9904S 
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GDC0941 PI3K inhibitor, puromycilation Selleckchem S1065 
bpV (hopic) PTEN inhibitor, 
puromycilation 
Calbiochem 203701 






Primary culture Worthington LK003150 
 
Bicuculline Competitive antagonist 
of GABAA receptors 





Reversible, selective blocker 
of Na+ channels, silencing of 
network activity 
Tocris 1069 
GlutaMax Primary culture Thermo Scientific 35050061  
FCS Primary culture Biochrom S 0615 
B27 supplement Primary culture Life Technologies 17504-044 
Penicillin/streptomycin Primary culture Life Technologies 15140122 
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1.6 Experimental cell models 
 
Different cell models were used in order to establish the most valuable systems to 
address the scientific questions reported in this thesis. To do so, cell lines and primary 
neuronal mix cultures were used. In this section, I characterize the conditions needed 
to maintain and grow cell lines and neurons isolated from mouse and rat in culture.  
1.6.1 Cell models  
 
COS-7, HEK293T and N1E-115 cells were grown and maintained for several passages 
in the incubator at 37°C and 5% CO2 in Dulbecco’s Modified Eagle Medium (DMEM) 
supplemented with 10 % fetal calf serum (FCS) and 1% penicillin/streptomycin (P/S).   
1.6.2 Primary neuronal cultures 
 
In order to study neuronal systems, I used cortex or hippocampal neurons obtained by 
microdissection from BL6 wild-type E16.5 mice, the DBN-KO E16.5 mice generated in 
the Eickholt lab, or P0-P1 Wistar rats. I established the long-term cultures (18-24 DIV) 
in the Eickholt lab from both mouse embryos and rat pups. In the following section, I 
describe the specific protocols needed to prepare and maintain neurons in culture.  
 
1.6.2.1 Mouse primary neuronal cultures 
 
Cortices or hippocampi were dissected from E16.5 C57BL/6 mice embryos. The 
dissected tissue was then dissociated in 0.5 mg/ml trypsin in HBSS for 15 minutes at 
37°C, washed twice in HBSS buffer, washed once in Neurobasal (NB) medium 
supplemented with 1% GlutaMAX, 2% B27, 1% P/S, and 102.29 µM (1:100, and then 
1:50 000 from stock solution) β-mercaptoethanol. Tissue was washed once in NB 
supplemented with 10% Horse Serum, and gently triturated in culture medium using a 
fire polished Pasteur pipette. Single cell suspension cells were plated on glass 
coverslips (Assistent) previously coated with Poly-Ornithine 1:50 (stock concentration 
1.5 µg/µl). Cultures were maintained in NB supplemented with 1% GlutaMAX, 2% B27 
and 1% P/S at 37°C and 5% CO2. After 3 days, astrocyte conditioned medium (ACM) 
was diluted in growing medium to a final concentration of 2x. Half the medium was 
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replaced every medium change, once a week. Neurons were plated at a density of 50 
000 cells/well in 24 well plates (TTP), 150 000 cells/well in 12-well plates, or 300 000 
cells/well in 6-well plates (TTP).  
1.6.2.2 Rat models 
 
Cortices or hippocampi were dissected from Winstar rats postnatal stages (P0-P1), 
dissociated in papain (Worthington) according to the papain dissociation system kit 
protocol. 20 000 hippocampal cells were plated on 35 mm glass-bottom (MatTek 
Corporation) previously coated with 1:50 Poly-Ornithine (stock concentration 1.5 
µg/µl). Two to four hours after plating the cells, 3 ml of the rat conditioned medium 
were pipetted in every dish. 
1.6.2.2.1 Growing medium 
 
Neurobasal medium supplemented with 1% GlutaMAX, 2% B27 and 1% P/S, and 
102.29 µM (1:100 and then 1:50000 from stock solution) β-mercaptoethanol. 
1.6.2.2.2 Generation of conditioned medium 
 
Conditioned medium was required for all the types of neurons in order to maintain them 
in long term culture. For primary mouse neuronal cultures Astrocytes conditioned 
medium was produced as described in the following section. To culture primary rat 
neurons from postnatal rat animals, conditioned medium was used. To generate this 
medium cortical and glial conditioned mediums were produced as described in the next 
sections.  
1.6.2.2.3 Astrocytes conditioned medium (ACM) for mouse primary cultures 
 
Cortices were dissected from E16.5 C57BL/mice embryos, dissociated in 0.5 mg/ml 
trypsin diluted in HBSS for 15 min at 37°C, washed twice in HBSS, washed once in 
growing medium: Neurobasal  medium supplemented with 1% GlutaMAX, 2% B27 and 
1% P/S, and 102.29 µM (1:100 and then 1:50000 from stock solution) β-
mercaptoethanol. Single cell suspension cells were plated on glass coverslips 
(Assistent) previously coated with 0.5% collage and grown in DMEM supplemented 
with 10% FCS and 1 % P/S until confluent. Then, astrocytes were washed once in 1x 
PBS and medium was replaced by Neurobasal (NB) medium supplemented with 1% 
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GlutaMAX, 2% B27 and 1% P/S, and 102.29 µM (1:100 and then 1:50000 from stock 
solution) β-mercaptoethanol. Medium replacement and collection were performed 
every 3 days.  
1.6.2.2.4 Rat conditioned medium 
 
This medium was prepared as follows: 80 % growing medium, 15% glial medium and 
5% cortical medium.  
1.6.2.2.5 Cortical conditioned medium for rat conditioned medium 
 
In order to prepare cortical conditioned medium necessary for culturing P0-P1 rat 
neurons, cortices were dissected from Wistar rats postnatal stages (P0-P1) dissociated 
in papain (Worthington) according to the Papain dissociation system kit protocol. 
Single cell suspension cells were plated in T75 flasks previously coated with 1:50 poly-
Ornithine (stock concentration 1.5 µg/µl) and grown in Neurobasal  medium 
supplemented with 1% GlutaMAX, 2% B27 and 1% P/S, and 102.29 µM (1:100 and 
then 1:50000 from stock solution) β-mercaptoethanol. Medium was changed after two 
days and a week later, before collection, which was done every 3 days.    
1.6.2.2.6 Glial conditioned medium 
 
Cortices were dissected from Wistar rats postnatal stages (P0-P1) dissociated in 
papain according to the papain dissociation system kit protocol. Single cell suspension 
cells were platted in T75 flasks previously coated with 0.5% collagen and growth in 
Minimum Essential Medium (MEM) supplemented with 10% horse serum and 20% 
glucose and 1% P/S until confluent. Then, medium is replaced with NB medium 
supplemented with 1% GlutaMAX, 2% B27 and 1% P/S, and 102.29 µM (1:100 and 
then 1:50000 from stock solution) β-mercaptoethanol. Medium collection was 
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1.7 Treatments and cell transfection  
 
In order to find regulatory inputs for DBN stability, cells were subjected to several 
treatments as described in the following section.  
 
1.7.1 Transfection in multiple cell lines 
 
SH-SY5Y, COS-7, N1E-115 or HEK293T cells were transfected 24 h after plating in 
24 well (1.9cm2) on cover slips, 12 well plates (3.8cm2), or 6 well plates (9.5cm2) using 
lipofectamine 2000 (Invitrogen), Opti-MEM as transfection reagent, and 1 µg, 1.5 µg, 
or 3 µg of plasmid, respectively. The transfection mix was prepared as suggested in 
the commercial Lipofectamine 2000 reagent protocol. Four hours after transfection the 
medium was replaced with fresh medium, and cells were incubated overnight at 37°C 
and 5% CO2 before cell fixation, cell lyses, or pulse labeling in pulse-chase 
experiments.  
1.7.2 Oxidative stress induction 
 
Stock concentrations of H2O2, paraquat or β-Amyloid Peptide (1-42) (Calbiochem) 
were prepared as follows. paraquat was dissolved in ddH2O to a stock concentration 
of 500 µM. H2O2 was freshly dissolved in ddH2O to a stock concentration of 97 µM.  Aβ 
was dissolved in Hexafluoroisopropanol to a stock concentration of 60µM.  14 DIV 
cortical neurons were treated with different concentrations of H2O2, paraquat or Aβ for 
24 h, and were then lysed for Western blot (6-well/12-well plates), or were fixed for 
immunocytochemistry (24-well plates).  
1.7.3 Neuronal stimulation and network silencing 
 
Neurons were treated with either 30 µM bicuculline to stimulate synaptic activity or 










Different classic assays such as SDS-page and western blot, as well as new assays, 
such as FUNCAT-PLA, were applied in this work. A detailed explanation of how these 
were performed is presented in this section.  
1.8.1 SDS-PAGE and Western blotting (WB) 
 
Neurons or cells were washed once with PBS and lysed in RIPA buffer supplemented 
with protease inhibitor and phosphatase inhibitors as specified in the consumables 
section. Equal amounts of protein were loaded in 8% acrylamide gels, transferred onto 
nitrocellulose membranes and blocked for 1 h in TBS supplemented with 1% Tween 
and 5% milk. Membranes were incubated 1 h in primary antibodies and washed three 
times for 5 min with TBS-Tween. They were then incubated for 1 h in secondary 
antibodies and washed three times for 5 min with TBS-Tween. Primary and secondary 
antibodies were prepared in TBS-Tween 5% milk.  
1.8.1.1 Membrane development and imaging 
 
ECL western blotting substrate for membrane development was applied for 1 minute 
and membranes were immediately developed with the system Fusion SL VILBER 
LOURMAT and digital images were captured for further analyses. Quantification of 
bands density was performed using ImageJ. The area of the band and the mean gray 
value were measured to obtain a relative density. For relative quantifications, 
measurements were normalized to loading control.  
1.8.2 Lentiviral infection of DBN-KO neurons 
 
Primary culture preparation was performed and 60 000 DBN-KO hippocampal neurons 
were grown on covers lips previously coated with 1:50 poly-O (stock concentration 1.5 
µg/µl). Neurons were infected with 50 µl of YFP-DBN or YFP lentiviruses after 2 DIV 
and later fixed after 22 DIV. Description of the DBN-KO model generation and specifics 
about the virus are described in the following section.  
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5.1.1.1 DBN knockout mice 
 
The DBN knockout (DBN-KO) mice line was developed in the Eickholt lab. The DBN 
knockout (DBN-KO) mice line was developed in the Eickholt lab. The Dbn1 mouse 
strain was used for the development of this mouse model from the embyonic stem cell 
clone. This clone, was obtained from KOMP Repository (www.komp.org) and the 
mouse model was generated at the Welcome Trust Sanger Institut (Skarnes, Rosen 
et.al.2011). The initial heterozygous mice holding a promoter-driven knockout allele 
(Dbn1tm1a(KOMP)Wtsi) were acquired from the KOMP Repository. Gene-trap 
cassette holding a constitutive null mutation was deleted after crossing with a FLP 
strain. Pre-conditional allele was validated by PCR and sequencing by Dr. Till Mack in 
the Eickholt Lab. This was followed by breading homozygote pre-conditional mice with 
a Cre strain (B6.C-Tg(CMV-cre)1Cgn/J, Jackson Laboratories) for the generation of 
homozygote null alleles and heterozygote null alleles. Genotyping with PCR was 
performed using the following primers: 
Genotyping Primers (5’-3’): 
F4: CGCCGGAACCGAAGTTCCTATT (forward primer for KO-PCR upstream of β-
gal+ neo cassette) 
F3: GAGGAGGTTAAAGGAGCAGTCTATCTTT (forward primer for WT-PCR end of 
exon 6)  
RS1: AGGAATACTCAAGTTCCTGTCGGACC (reverse primer between exon 6 and 
exon 7)  
5.1.1.2 YFP-virus 
 
DBN-A wild-type-YFP and YFP lentiviruses with a synapsin promoter were generated 





Neurons or cells were fixed with 4% PFA, 4% sucrose  or 4% paraformaldehyde (PFA), 
respectively for 20 min, washed three times with PBS, permeabilized for 15 min in 0.5% 
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triton in PBS-MC (PH7,4) and blocked for 1 h or overnight in 4% goat serum.  
Coverslips were incubated with primary antibodies for 1 h at room temperature, 
washed three times for 5 min with PBS, incubated with secondary antibodies for 1 h at 
room temperature and washed three times with PBS. Coverslips were incubated with 
Hoechst (1:50000 dilution) for 10 min and mounted using Mowiol. Primary and 
secondary antibodies were diluted in blocking solution. Antibodies were prepared in 
4% goat serum as follows: Drebrin (mouse monoclonal [M2F6], GenTex) 1:200, α-
tubulin (mouse monoclonal antibody, Sigma Aldrich) 1: 400, α–tubulin (rat monoclonal 
[YL1/2] Abcam) 1:50. Secondary antibodies anti-mouse alexa 568, anti-mouse alexa 
488 and anti-rat alexa 568 (Invitrogen) were prepared in a dilution of 1:1000 in PBS 
2% BSA, 1% goat serum and 1% Sodium azide.  
1.8.4 Pulse-chase experiments in 293T cells 
 
150 000 cells (HEK293-T) were plated on poly-ornithine coated 12-well plates and 
growth in DMEM medium supplemented with 10% FCS and 1% P/S for 24 h at 37°C 
and 5% CO2. After 24 h the cells were transfected with Lipofectamine using 1.5 µg of 
plasmid DNA. Twenty four hours after transfection, cells were washed in pre-warmed 
methionine free DMEM medium supplemented with 10% FCS and 1% P/S. Cells were 
incubated for 1 h. Later, the medium was replaced by labeling medium: 1 mM 
azidohomoalanine (AHA) in methionine free DMEM medium supplemented with 10% 
FCS and 1% P/S. Cells were pulse-labeled for 1 h, washed once in complete medium 
and twice in PBS, and followed by cell lyses (no chase) or chase for: 24 h, 48 h and 
72 h in complete medium before cell lyses. Cells were lysed in 150 µl of RIPA buffer 
supplemented with 1x protease inhibitor cocktail and 1x phosphatase inhibitors. Click-
chemistry in the protein lysates was then performed.  
1.8.5 Click-chemistry protein lysates 
 
100 µl of cell lyses were collected and click-chemistry was performed using the Click-
it Protein reaction buffer kit as suggested in the protocol provided. Cycloaddition was 
used with biotin-alkyne and precipitated protein was re-suspended in 1x Roti-Load 
sample buffer for western blot analyses. Labeled proteins were detected with 
Streptavidin-HRP (1:1500) and later stripped for 30 min at 45°C to further blot with anti-
Flag 1:100,000. As loading control anti-α-Tubulin was used.  
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1.8.6  FUNCAT-PLA 
 
Between 30 000-50 000 hippocampal rat neurons were plated on poly-ornithine coated 
35 mm glass-bottom (MatTek Corporation) and growth in rat conditioned medium (see 
section 2.3.2.4). 18-21 DIV neurons were incubated for 2 h with Neurobasal A-Met free 
+ 1% glutaMax, 2% B27 and 4 mM AHA, 40 µM Anisomycin (Aniso) or Methionine 
(Met). Conditioned medium for each plate was kept in the incubator during pulse-
labeling to be re-used during the chase. After pulse-labeling with AHA or Met-control, 
cells were washed twice with PBS-MC (pH 7.4) and fixed with 4% PFA 4% Sucrose in 
PBS-MC (PH 7.4) (no chase) or chase in own medium for: 24 h or 68 h. Time points 
were coordinated to end at the same time. Fixed cells were permeabilized for 15 min 
with 0.5% triton in PBS-MC (pH 7.4), blocked for 1 h in 4% goat serum in PBS (pH 7.4) 
and washed twice with PBS pH 7.8 before click-chemistry. 
 
Click-chemistry reaction for FUNCAT-PLA (1 reaction) 
1 ml PBS, pH 7.8 
1 µl of triazole ligand stock (Stock 200mM) 
1 µl of freshly prepared TCEP (500mM) 
0.5 µl biotin-alkyne (Stock 50mM) 
1 µl CuSO4 solution (200mM) 
 
Cells were incubated in the click-chemistry reaction at room temperature overnight and 
then a second permeabilization step was performed in 15 min with 0.5% triton in PBS-
MC (pH 7.4). Cells were washed twice with PBS-MC (pH 7.4) and blocked for 1h in 4 
% goat serum in PBS (pH 7.4). Incubation with primary antibodies was followed and 
performed for 1.5 h at room temperature. Antibodies were prepared in blocking buffer 
at indicated dilutions (See table 1). DBN (mouse monoclonal [M2F6]) antibody was 
always used in these experiments.  
 
1.8.7 High-resolution fluorescence in situ hybridization (Panomics probes) 
 
These experiments were fully performed in the Schuman Lab. To do so, high-resolution 
fluorescence in situ hybridization probes were designed to detect DBN mRNA in rat 
neurons. Hippocampal rat neurons (21-24 DIV) were fixed with PFA-sucrose and 
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permeabilized before target hybridization. The FISH protocol was followed exactly as 
suggested in the Afimetrix kit manual (QuantiGene ViewRNA Cell Assay User Manual; 
P/N 1880).  
 
The procedure consisted of three main steps: 
 
• Fixing cells and hybridization (in this step the transcript-specific probe is 
applied). 
• Amplification (in this step the signal is amplified). 
• Antibody staining (MAP2 and phalloidin in this work). 
 
1.8.8 Puromycilation (Puro) 
 
For puromycilation, neurons or N1E-115 cells were incubated with 1 µM (for PLA) or 4 
µM (for WB) puromycin or without puromycin as a control for 3 or 5 min (as indicated), 
in medium at 37 °C in an incubator with 5% CO2. After incubation, two fast washes 
with pre-warmed PBS-MC were performed and cells were either fixed for 20 min in 
PFA-sucrose or lysed in RIPA buffer for WB analyses.  In neurons, the medium in 
which they were grown was always used for any drug treatments. As a protein 
synthesis inhibitor 40 µM anisomycin was applied 30 min to 1 h before puromycilation 
and in the presence of puromycin.  
After fixation, cells were washed with PBS, permeabilized for 15 min with 0.5% triton 
in PBS-MC (pH 7.4), blocked for 1 h in 4% goat serum in PBS (pH 7.4) and followed 
by the proximity ligation assay as described in section 2.3.6 using the puromycin and 
rabbit polyclonal DBN (homemade; Eickholt Lab) antibodies for 1.5h at room 
temperature (see table 1 for antibody dilutions). 
After cell lyses, samples were centrifuged, prepared as described in section 2.3.1, and 
analyzed with the puromycin antibody.  
1.8.9 Proximity ligation assay (PLA) 
   
This assay was applied for FUNCAT-PLA, Puro-PLA and PLA experiments modifying 
the antibodies as needed. This protocol was optimized following the directions of the 
Duolink In Situ manual and as described in the following section. 




After primary antibody incubation, cells were washed three times for 5 min with PBS 
(pH 7.4) and incubated for 1 h at 37°C with freshly prepared PLA-probes (1:10) in a 
semi-wet chamber.  
 
PLA probes (1 reaction = 80 µl) 
8 µl PLA + (Probe Anti-Rabbit PLUS) 
8 µl PLA – (Probe Anti-Mouse MINUS) 
64 µl blocking buffer 
 
After incubation with the PLA probes, cells were washed three times for 5 min with 
washing buffer A. Ligation was performed for 30 min at 37°C in a semi-wet chamber. 
 
Ligation (1 reaction = 80 µl) 
16 µl ligation-stock (PLA kit)  
5 µl ligase 
62 µl H2O  
 
After ligation, two washing steps with washing buffer A were performed, the 
amplification reaction was prepared and cells were incubated for 100 min at 37°C in 
this solution. 
 
Amplification (1 reaction = 80 µl) 
16 µl amplification-stock (PLA kit)  
1 µl polymerase 
63 µl H2O  
 
After amplification, two immediate washing steps with washing buffer B were 
performed followed by two of 10 min each, one with 0.01x washing buffer B and one 
with PBS. Finally, cells were incubated for 10 min with 4% PFA 4% sucrose in PBS for 
a second fixation step. The last step in this protocol is the staining of neurons with the 
MAP2 neuronal marker. For this purpose, cells were incubated in blocking solution 
overnight at 4°C and incubated with the MAP2 antibody for 1.5 h at room temperature. 
After three washing steps with PBS, cells were incubated with anti-guinea pig antibody 
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for 1h and further washed three times with PBS. Finally, nuclear staining was 
performed with Hoechst for 5 min and washed with PBS. Cells were maintained in PBS 




In the Eickholt Lab, the images of cells were captured using a Confocal Laser Scanning 
Microscope Leica TCS SP8 using a 63x oil objective. Images were acquired with a 
resolution of 1024 x 1024 pixels through the entire sample as z-stacks size 0.5 µm. 
Laser intensities and gain were defined for every experiment and maintained without 
changes within an experiment.  
In the Schuman Lab, the images were captured using a LSM780 confocal microscope 
(Zeiss) using a 40x oil objective. Images were acquired with a resolution of 1024 x 
1024 pixels through the entire sample as z-stacks size 0.5 µm. Laser intensities and 
gain were defined for every experiment and maintained without changes within an 
experiment.  
 
1.10 Analyses and statistical tests 
 
1.10.1 Data normalization and calculations 
 
To plot the data obtained from the pulse-chase experiments, we reasoned that at the 
time point 0 h chase, maximum protein labeling has been achieved. Therefore, we 
normalized the data considering AHA 0 h as 100%. In pulse chase experiments with 
293T cells protein half-lives were calculated individually for every experiment using the 
exponential decay equation from the curves (0 h and 72 h chase) from multiple 
experiments (n ≥ 3) and later mean values between half-lives were obtained. However, 
in pulse chase experiments in neurons the protein half-live for DBN was calculated 
using the exponential equation from the curve from three independent experiments.  
Data was always normalized as percentage of control.  
T-tests were applied in all cases and P-values were indicated on every figure. The 
standard error of the means (SEMs) were calculated and are represented in the error 
bars of the bar plots presented in the results section.  
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1.10.2 Image analyses 
 
Five to ten images per condition were captured and processed for analysis in FIJI 
(Schindelin et al., 2012). Maximal projections were used for all quantitative analyses. 
All the images obtained from the FUNCAT-PLA, Puro-PLA and Panomics experiments 
were analyzed using our customize Plugin for PLA. The details for this plugin are 
explained in the results section X since this was part of the thesis work and the detailed 
script in the supplemental information section. Overall, PLA puncta and the area these 
occupied were quantified on a mask for a cell volume marker. In neurons: MAP2 and 
in N1E-115 cells: actin-stain. All the puncta not overlapping or in the close proximity 
with the respective cell volume marker were excluded from the analyses. Finally, PLA 
to cell volume marker ratios were calculated and experimental conditions were always 
normalized as percentage of control. The signal from a whole image was considered 
as the total or global signal in the case of further analyses to compare soma and 
dendrites.  
1.10.3 Dendrites and soma PLA/Panomics analyses  
 
A plugin to manually select the Soma in neurons was also developed for the analyses 
of this work (see supplemental figures for script). After selection of soma on a specific 
image, a subfolder was automatically created where the storage of soma pictures were 
kept. PLA analyses were later run on the specific folder and results were further 
analyzed in Excel. The following calculations were performed to quantify the signal 
along dendrites: 
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7 Supplemental information 
 
7.1 Supplementary data   
 
In this section I include the codes generated by Viktor Dinkel for the FIJI Plugin Script 
that I applied for the PLA data analyses. Three codes are shown: PLA analysis, PLA 
dendrites and PLA soma.  
 


















public class PLA_Analysis extends ImagePlus implements PlugIn { 
 
 // STRING FOR OS 
 public static String os_system = ""; 
 public static String os_slash = ""; 
  
    /////////// ---------- CONFIGURATION 
    public static Double areaMaxValue = 9999999.0;   // AREA UPPER 
BOUND FOR MAX PLA-SIZE 
    public static Boolean fixedThreshold = true; // SET TO 0 IF YOU 
WANT TO DEFINE IT AUTOMATICALLY, OTHERWISE YOUR FIXED VALUE WILL BE 
USED 
    public static Integer autoThreshold = 0;         
    public static String map2ThresholdMethod; 
    /////////// -------------------------------------------- 
 
    public static String version = "0.86"; 
    public static String path = ""; 
    public static String pathChannels; 
    public static String pathAnalysis; 
    public static ArrayList<String> imageFiles; 
    public static ArrayList<String> plaResults; 
     
 // Format of singleResults: 
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    public static Integer headerElements; 
    public static ArrayList<String> csvHeader; 
    public static String singleResults; 
    public static String allResults; 
    public static Integer plaThreshold; 
     
    public static Double map2Area; 
    public static Double plaArea; 
 public static Double totalIntDen; 
 public static Double maxIntDen; 
 public static Double minIntDen; 
    public static Double sumMAP2Area; 
    public static Double sumPLAArea; 
 public static Double sumIntDen; 
 
    public static Integer countedAreas; 
    public static Integer numAreas; 
 
    public void run(String arg) { 
 
    // Initialization 
     
    imageFiles = new ArrayList<String>(); 
    plaResults = new ArrayList<String>(); 
    headerElements = 7; 
    csvHeader = new ArrayList<String>(); 
    singleResults = ""; 
    allResults = ""; 
    plaThreshold = 70; 
    map2Area = 0.0; 
    plaArea = 0.0; 
    sumMAP2Area = 0.0; 
    sumPLAArea = 0.0; 
    countedAreas = 0; 
    numAreas = 0; 
 totalIntDen = 0.0; 
 maxIntDen = 0.0; 
 minIntDen = 99999999.99; 
 sumIntDen = 0.0; 
     
    os_system = System.getProperty("os.name"); 
    if (os_system.contains("Mac")) 
      os_slash = "/"; 
    else os_slash = "\\"; 
 
    IJ.log("-----------------[ Start PLA_Analysis V"+version+" ]----
-------------"); 
    IJ.log("System information: "+os_system+" separator: 
"+os_slash); 
    path = IJ.getDirectory("Choose Directory of Image File(s)"); 
    IJ.log("- Directory: "+path); 
     
    // Ask for automatic/fixed MAP2-threshold 
 GenericDialog gd_map = new GenericDialog("MAP2-Threshold"); 
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 gd_map.addMessage("Do you want to define a fixed MAP2-threshold 
for all files? \n\n\nSet the value to 0 if the threshold has to be 
defined automatically for each image. "); 
 gd_map.addNumericField("Threshold: ", autoThreshold, 0); 
 gd_map.showDialog(); 
    if (gd_map.wasCanceled()) return; 
    autoThreshold = 
Math.max(0,Math.min((int)gd_map.getNextNumber(),254)); 
    if (autoThreshold == 0) {fixedThreshold = false; 
map2ThresholdMethod = "Auto";} 
    else {fixedThreshold = true; map2ThresholdMethod = 
autoThreshold.toString();} 
 
     // Ask for automatic/fixed MAP2-threshold 
    GenericDialog gd_pla = new GenericDialog("PLA-Threshold"); 
    gd_pla.addMessage("Change the Number if you want a different 
PLA-threshold for all files. Otherwise click OK."); 
    gd_pla.addNumericField("Threshold: ", plaThreshold, 0); 
    gd_pla.showDialog(); 
    if (gd_pla.wasCanceled()) return; 
    plaThreshold = Math.max(0, 
Math.min((int)gd_pla.getNextNumber(),254)); 
     
    final File folder = new File(path); 
    imageFiles = listFilesForFolder(folder); 
    createPaths(path); 
     
    // Create the subfolders 
 String imageName; 
  
 IJ.log("---------------------- Start processing images"); 
 String HTMLString = ""; 
     for (int i=0; i<imageFiles.size(); i++){ 
      plaArea = 0.0; 
      map2Area = 0.0; 
   totalIntDen = 0.0; 
   maxIntDen = 0.0; 
   minIntDen = 99999999.99; 
 
      imageName = imageFiles.get(i); 
            if (csvHeader.size() < headerElements) 
                csvHeader.add("imagename"); 
            singleResults += imageName+";"; 
            IJ.log("Image: "+imageName); 
            processImage( imageName ); 
            measureImage( imageName ); 
            resetAll(); 
 
            if (i<imageFiles.size()-1) 
            IJ.log("------------------------------"); 
 
            sumMAP2Area += map2Area; 
            sumPLAArea += plaArea; 
   sumIntDen += (totalIntDen/countedAreas); 
             
            HTMLString = makeHTML(i, imageName, false, HTMLString); 
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            allResults = allResults + singleResults+"\n"; 
            singleResults=""; 
            } 
     makeHTML(0, "", true, HTMLString); 
     writeCSS(); 
        writeCSV(); 
  
    System.gc(); 
 IJ.log("-----------------[ End PLA-Plugin ]-----------------"); 
 return; 
    } 
 
    public String convertToPNG(String imageName){ 
        String pathHTML = path+"pla"+os_slash+"HTML"+os_slash; 
        //IJ.log(pathHTML); 
        Boolean success = (new File(pathHTML)).mkdirs(); 
     if (!imageName.substring(imageName.length()-
4).toLowerCase().equals(".png")) 
     { 
     //ImagePlus imp = IJ.openImage(path+"\\"+imageName); 
     ImagePlus imp = IJ.openImage(path+"/"+imageName); 
     imageName = imageName.substring(0, imageName.length()-
4)+".png"; 
     IJ.saveAs(imp, "png", pathHTML+imageName); 
     IJ.log("... converted to .png "); 
     } 
     return imageName; 
    } 
     
    public ArrayList<String> listFilesForFolder(final File folder) { 
     ArrayList<String> dirFiles = new ArrayList<String>(); 
     ArrayList<String> fileFormats = new ArrayList<String>() {{ 
     add(".jpg"); 
     add(".tif"); 
     add(".png"); 
     add(".gif"); 
     add(".bmp"); 
        }}; 
        Integer k = 0; 
     for (final File fileEntry : folder.listFiles()) { 
         if (fileEntry.isDirectory()) { 
             //this is for recursive search of the directory 
             //listFilesForFolder(fileEntry); 
             //IJ.log("Skipped directory: 
"+fileEntry.getName()); 
         } else { 
             String fileName = fileEntry.getName(); 
              
             for (int i=0; i<fileFormats.size(); i++){ 
              if (fileName.contains(fileFormats.get(i))){ 
               // replace spaces 
                        if (fileName.contains(" ")){ 
                File newFile = new 
File(path+fileName.replace(" ", "_")); 
                fileEntry.renameTo(newFile); 
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                fileName = fileName.replace(" ", 
"_"); 
                            } 
                
                        // convert the image into png-format 
                        IJ.log("start converting file: "+fileName); 
                        convertToPNG(fileName); 
 
                        //if the image is not added for processing 
                        if (!dirFiles.contains(fileName)) 
                                { 
                                    IJ.log("_"+k.toString()+". 
Image-File: "+fileName); 
                                    dirFiles.add(fileName); 
                                } 
                                k++; 
                                break; 
              } 
             } 
         } 
     } 
 return dirFiles; 
 } 
     
    public void createPaths(String thispath){ 
     pathChannels = thispath + 
"pla"+os_slash+"temp"+os_slash+"channels"; 
     pathAnalysis = thispath + "pla"+os_slash+"analysis"; 
     Boolean success = (new File(pathChannels)).mkdirs(); 
        Boolean success2 = (new File(pathAnalysis)).mkdirs(); 
    } 
 
    public void processImage( String imageName ){ 
        splitChannels( imageName ); 
        maskMAP2(imageName); 
        maskPLA(); 
        return; 
    } 
 
    public void measureImage( String imageName ){ 
        plaArea = measurePLA( imageName ); 
        map2Area = measureMAP2( imageName ); 
        return; 
    } 
 
    public void splitChannels( String imageName ){ 
        ImagePlus imp = IJ.openImage(path+imageName); 
        IJ.run(imp, "Split Channels", ""); 
 
        IJ.log("SAVING CHANNELS AT: "+pathChannels); 
        IJ.selectWindow(imageName+" (green)"); 
        IJ.saveAs("TIF", pathChannels+os_slash+"green.tif"); 
 
        IJ.selectWindow(imageName+" (blue)"); 
        IJ.saveAs("TIF", pathChannels+os_slash+"blue.tif"); 
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        IJ.selectWindow(imageName+" (red)"); 
        IJ.saveAs("TIF", pathChannels+os_slash+"red.tif"); 
 
        IJ.run("Close All", ""); 
        return; 
    } 
 
    public void maskMAP2( String imageName ){ 
        IJ.log("MASKING MAP 2 :" +imageName); 
        ImagePlus imp = 
IJ.openImage(pathChannels+os_slash+"green.tif"); 
        imp.show(); 
 
        ImageProcessor ip = imp.getProcessor(); 
        Integer thisThreshold; 
        if (!fixedThreshold){ 
            thisThreshold = ip.getAutoThreshold();} 
        else{ 
            thisThreshold = autoThreshold;} 
        if (csvHeader.size() < headerElements) 
            csvHeader.add("map2-thr;pla-thr"); 
        singleResults += String.valueOf(thisThreshold)+";"; 
        singleResults += String.valueOf(plaThreshold)+";"; 
        IJ.log("- MAP2-Threshold (Mask): 
"+thisThreshold.toString()); 
         
        IJ.setThreshold(imp, 0, thisThreshold); 
        IJ.run("Threshold", "thresholded remaining black slice");  
         
        IJ.run(imp, "Convert to Mask", ""); 
        IJ.run(imp, "Dilate", ""); 
 
        ImagePlus imp2 = new Duplicator().run(imp); 
         
        IJ.saveAs("png", 
pathAnalysis+os_slash+"DIL_MASK_"+imageName.replace(".tif","")+".png
"); 
        imp.close(); 
        imp2.show(); 
        return; 
    } 
 
    public void maskPLA(){ 
        ImagePlus imp = 
IJ.openImage(pathChannels+os_slash+"red.tif"); 
        imp.show(); 
         
        IJ.setThreshold(imp, 0, plaThreshold); 
        IJ.run("Threshold", "thresholded remaining black slice");  
             
        IJ.run(imp, "Convert to Mask", ""); 
        IJ.run(imp, "Create Mask", ""); 
   
        imp.close(); 
   
        return; 
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    } 
 
    public Double measurePLA(String imageName){ 
        //ImagePlus dilGreen = 
IJ.openImage(pathAnalysis+"\\DIL_MASK_"+imageName+".jpg"); 
        //dilGreen.show(); 
        //String origTitle = dilGreen.getTitle(); 
        IJ.selectWindow("mask"); 
        IJ.run("Set Measurements...", "area mean integrated gray 
redirect=DUP_green.tif decimal=3"); 
        IJ.run("Analyze Particles...", "size=0-Infinity 
circularity=0.00-100.00 show display clear add in_situ"); 
 
        IJ.selectWindow("Results"); 
   
        ResultsTable rt = ResultsTable.getResultsTable(); 
        Integer numResults = rt.getCounter(); 
        Integer numColumns = rt.getLastColumn(); 
  IJ.log("- Amount of columns: "+numColumns.toString()); 
        Double area, mean, intDen, rawIntDen, totalArea; 
        area=0.0; mean=0.0; intDen =0.0; rawIntDen=0.0; 
totalArea=0.0; 
  countedAreas = 0; 
        numAreas = numResults; 
         
        for (int i = 0; i<numResults; i++){ 
            area = rt.getValueAsDouble(0,i); 
            mean = rt.getValueAsDouble(1,i); 
   intDen = rt.getValueAsDouble(20,i); 
   rawIntDen = rt.getValueAsDouble(25,i); 
 
   //IJ.log("- IntDen "+intDen.toString()); 
 
            String addExcluded = ""; 
            if (area > areaMaxValue) 
                addExcluded = " - TOO LARGE!!!"; 
            //IJ.log("A: "+String.valueOf(area)+addExcluded); 
            //IJ.log("M: "+String.valueOf(mean)); 
            //IJ.log("---Area: "+String.valueOf(area)+" Mean: 
"+String.valueOf(mean)); 
            if (mean>0.0 && area <= areaMaxValue){ 
                totalArea += area; 
                countedAreas++; 
    totalIntDen += intDen; 
     
    if (intDen > maxIntDen) maxIntDen = intDen; 
    if (intDen < minIntDen) minIntDen = intDen; 
     
            } 
        } 
 
        IJ.log("- PLA Area: "+String.valueOf(totalArea)+" (counted: 
"+countedAreas.toString()+"/"+numResults.toString()+") intden: 
"+intDen.toString()+" rawint: "+rawIntDen.toString()); 
        IJ.saveAs("Results", 
pathAnalysis+os_slash+imageName+"_Results.csv"); // XLS OR CSV 
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  // just _Results.xls contains PLA area 
        IJ.run("Close"); 
 
        IJ.selectWindow("mask"); 
        IJ.saveAs("tif", 
path+os_slash+"pla"+os_slash+"temp"+os_slash+"red_mask.tif"); 
        Double ret; 
        ret = totalArea; 
        if (csvHeader.size() < headerElements) 
            csvHeader.add("pla"); 
        singleResults += String.valueOf(ret).replace(".", ",")+";"; 
   
  if (csvHeader.size() < headerElements) 
            csvHeader.add("min-pla-int;max-pla-int;mean-pla-
int;int/map2-ratio"); 
   
  double thisMeanIntDen = (totalIntDen/countedAreas); 
  singleResults += String.valueOf(minIntDen).replace(".", 
",")+";"+String.valueOf(maxIntDen).replace(".", 
",")+";"+String.valueOf(thisMeanIntDen).replace(".", ",")+";"; 
 // String.format("%.2f",maxIntDen) 
   
        return ret; 
    } 
 
    public Double measureMAP2(String imageName){ 
        ImagePlus imp = 
IJ.openImage(pathChannels+os_slash+"green.tif"); 
        imp.show(); 
 
        ImageProcessor ip = imp.getProcessor(); 
        Integer thisThreshold; 
        if (!fixedThreshold) 
            { 
            thisThreshold = ip.getAutoThreshold(); 
            autoThreshold = thisThreshold; 
            } 
        else{ 
            thisThreshold = autoThreshold;} 
         
        IJ.setThreshold(imp, 0, thisThreshold); 
        IJ.log("- MAP2-Threshold (Measure): 
"+thisThreshold.toString()); 
        IJ.run("Threshold", "thresholded remaining black slice");  
        IJ.run(imp, "Convert to Mask", ""); 
        IJ.run(imp, "Create Selection", ""); 
        IJ.run("Set Measurements...", "area mean gray redirect=None 
decimal=3"); 
        IJ.run(imp, "Measure", ""); 
        IJ.run(imp, "Select None", ""); 
        imp.close(); 
        IJ.selectWindow("Results"); 
 
        ResultsTable rt = ResultsTable.getResultsTable(); 
        Double thisMap2Area = rt.getValueAsDouble(0,0); 
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        //IJ.log("- MAP2 Area: "+String.valueOf(thisMap2Area)+" 
micron? = "+(String.valueOf(thisMap2Area)).contains(".")); 
             
        IJ.saveAs("Results", 
pathAnalysis+os_slash+imageName+"_NeuronArea__Results.csv"); // XLS 
OR CSV 
 //_NeuronArea_Results.xls contains MAP2 Area 
        IJ.run("Close"); 
 
        IJ.log("-- PLA/MAP2 - RATIO: 
"+String.valueOf(plaArea/thisMap2Area)+"   * 100 = 
"+String.valueOf((plaArea/thisMap2Area)*100)); 
        if (csvHeader.size() < headerElements) 
            csvHeader.add("map2"); 
        singleResults += 
String.valueOf((totalIntDen/countedAreas)/thisMap2Area).replace(".", 
",")+";"+String.valueOf(thisMap2Area).replace(".", ",")+";"; 
        if (csvHeader.size() < headerElements) 
            csvHeader.add("pla/map2-ratio"); 
        singleResults += 
String.valueOf(plaArea/thisMap2Area).replace(".", ",")+";"; 
        Double ret = thisMap2Area; 
 
        return ret; 
    } 
 
    public String makeHTML(Integer i, String imageName, Boolean 
writeFileNow, String HTMLString){ 
     String pathHTML = 
path+os_slash+"pla"+os_slash+"HTML"+os_slash+i.toString()+os_slash; 
     Boolean success = (new File(pathHTML)).mkdirs(); 
        imageName = imageName.replace(".tif",""); 
 
        if (writeFileNow){ 
            // make new results file 
                IJ.log("------------- SUMMARY -------------"); 
                Double meanPLA = sumPLAArea/imageFiles.size(); 
                Double meanMAP2 = sumMAP2Area/imageFiles.size(); 
    Double meanIntDen = 
sumIntDen/imageFiles.size(); 
                Double meanRatio = ((meanPLA/imageFiles.size()) / 
(meanMAP2/imageFiles.size()))*100; 
                IJ.log("SUM of Areas [PLA] 
"+String.valueOf(sumPLAArea)+" / [MAP2] 
"+String.valueOf(sumMAP2Area)+" = 
"+String.valueOf(sumPLAArea/sumMAP2Area)); 
                IJ.log("MEAN Value [PLA] "+String.valueOf(meanPLA)+" 
/ [MAP2] "+String.valueOf(meanMAP2)+" = 
"+String.valueOf(meanRatio)); 
                 
            String HTMLHeader = "<html><head><title>PLA-
Analysis</title><link href=\"../HTML/style.css\" rel=\"stylesheet\" 
type=\"text/css\"></head><body><div 
id=\"main_container\"><h1>Analysis of PLA</h1><div 
class=\"content_left\"><p>MAP2-Threshold</p><p>PLA-
Threshold</p><p>Analyzed images</p><p>Mean-PLA</p><p>Mean-









href=\"ALL_RESULTS.csv\" target=\"blank\"> >> 
ALL_RESULTS.csv</a></p></div><div class=\"clear_float\"></div>"; 
            String fullHTML = HTMLHeader+HTMLString; 
            try { 
            PrintWriter writer = new 
PrintWriter(pathAnalysis+os_slash+"results_summary.html", "UTF-8"); 
            writer.println(fullHTML); 
            writer.close(); 
            }catch (Exception ex){  
            } 
 
            return HTMLString; 
        } 
 
        else { 
 
            ImagePlus green = 
IJ.openImage(pathChannels+os_slash+"green.tif"); 
            green.show(); 
            ImagePlus red = 
IJ.openImage(pathChannels+os_slash+"red.tif"); 
            red.show(); 
            ImagePlus blue = 
IJ.openImage(pathChannels+os_slash+"blue.tif"); 
            blue.show(); 
 
            IJ.run(green, "Merge Channels...", "c1=red.tif 
c2=green.tif c3=blue.tif create"); 
            IJ.selectWindow("Composite"); 
            IJ.run("Split Channels", ""); 
 
            IJ.selectWindow("C1-Composite"); 
            IJ.saveAs("png", pathHTML+"red_orig.png"); 
            IJ.run("Close"); 
            IJ.selectWindow("C2-Composite"); 
            IJ.saveAs("png", pathHTML+"green_orig.png"); 
            IJ.run("Close"); 
            IJ.selectWindow("C3-Composite"); 
            IJ.saveAs("png", pathHTML+"blue_orig.png"); 
            IJ.run("Close"); 
 
            ImagePlus red_mask = 
IJ.openImage(path+os_slash+"pla"+os_slash+"temp"+os_slash+"red_mask.
tif"); 
            red_mask.show(); 
            IJ.run(red_mask, "Invert", ""); 
            IJ.run(red_mask, "RGB Color", ""); 
            ImagePlus green_dil = 
IJ.openImage(pathAnalysis+os_slash+"DIL_MASK_"+imageName+".png"); 
            green_dil.show(); 
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            ImagePlus blue_orig = 
IJ.openImage(pathHTML+"blue_orig.png"); 
            blue_orig.show(); 
             
            //IJ.log("HERE MERGE CHANNELS!"); 
            //IJ.selectWindow("red_mask.tif"); 
            //IJ.run("8-bit", ""); 
             
            Integer red_bitDepth = red_mask.getBitDepth(); 
            Integer green_bitDepth = green_dil.getBitDepth(); 
            Integer blue_bitDepth = blue_orig.getBitDepth(); 
            IJ.log("Bit-depths: "+red_bitDepth+" "+green_bitDepth+" 
"+blue_bitDepth); 
            if (( red_bitDepth != green_bitDepth ) || (red_bitDepth 
!= green_bitDepth ) || ( green_bitDepth != blue_bitDepth )){ 
                IJ.run(red_mask, "RGB Color", ""); 
                IJ.run(green_dil, "RGB Color", ""); 
                IJ.run(blue_orig, "RGB Color", ""); 
            } 
            
            IJ.run(green_dil, "Merge Channels...", "c1=red_mask.tif 
c2=DIL_MASK_"+imageName+".png c3=blue_orig.png create"); 
 
            IJ.selectWindow("Composite"); 
            IJ.saveAs("png", pathHTML+"red_green_composite.png"); 
            IJ.run("Close"); 
 
            ImagePlus green2 = 
IJ.openImage(pathChannels+os_slash+"green.tif"); 
            green2.show(); 
            IJ.run(green2, "Invert", ""); 
            IJ.saveAs("png", pathHTML+"green_inverted.png"); 
            IJ.run("Close"); 
            ImagePlus red2 = 
IJ.openImage(pathChannels+os_slash+"red.tif"); 
            red2.show(); 
            IJ.run(red2, "Invert", ""); 
            IJ.saveAs("png", pathHTML+"red_inverted.png"); 
            IJ.run("Close"); 
            ImagePlus blue2 = 
IJ.openImage(pathChannels+os_slash+"blue.tif"); 
            blue2.show(); 
            IJ.run(blue2, "Invert", ""); 
            IJ.saveAs("png", pathHTML+"blue_inverted.png"); 
            IJ.run("Close"); 
    
   // SAVE PLA MASK 
   ImagePlus imp = 
IJ.openImage(pathChannels+os_slash+"red.tif"); 
   imp.show(); 
   IJ.setThreshold(imp, 0, plaThreshold); 
   IJ.run("Threshold", "thresholded remaining black 
slice");  
   IJ.run(imp, "Convert to Mask", ""); 
   IJ.run(imp, "Create Mask", ""); 
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   IJ.saveAs("png", 
pathAnalysis+os_slash+"PLA_MASK_"+imageName+".png"); 
   imp.close(); 
   IJ.run("Close"); 
 
            // append HTML-data to HTML-File 


















class=\"lower_content_box\">    <a 
href=\"../HTML/"+i.toString()+"/red_orig.png\" target=\"blank\"><img 
src=\"../HTML/"+i.toString()+"/red_orig.png\" /></a>    <a 
href=\"../HTML/"+i.toString()+"/red_inverted.png\" 
target=\"blank\"><img 
src=\"../HTML/"+i.toString()+"/red_inverted.png\" /></a></div>   
<div class=\"lower_content_box\"><a 
href=\"PLA_MASK_"+imageName+".png\" target=\"blank\"><img 
src=\"PLA_MASK_"+imageName+".png\" /></a>&nbsp;<b>PLA Mask</b><br 
/><br />&nbsp;<b>Intensity</b><br />&nbsp;min: 
"+String.format("%.2f",minIntDen)+"<br />&nbsp;max: 
"+String.format("%.2f",maxIntDen)+"<br />&nbsp;&empty;: 
"+String.format("%.2f", (totalIntDen/countedAreas))+"</div>     <div 
class=\"lower_content_box\">    <a 
href=\"../HTML/"+i.toString()+"/green_orig.png\" 
target=\"blank\"><img 





            //countedAreas.toString()+"/"+numAreas.toString() 
            if (csvHeader.size() < headerElements) 
                csvHeader.add("counted_areas;total_areas"); 
            singleResults += 
String.valueOf(countedAreas.toString())+";"; 
            singleResults += 
String.valueOf(numAreas.toString())+";"; 
            if (i == imageFiles.size()-1){ 
                HTMLString+="</div></body></html>"; 
                } 
            } 




    return HTMLString; 
    } 
 
    public void writeCSS(){ 
        String pathCSS = 
path+os_slash+"pla"+os_slash+"HTML"+os_slash; 
        String cssString = "@font-face {font-family: 'Dosis';font-
style: normal;font-weight: 400;src: local('Dosis Regular'), 
local('Dosis-Regular'), 
url(http://themes.googleusercontent.com/static/fonts/dosis/v2/xIAtSa
glM8LZOYdGmG1JqQ.woff) format('woff');} body, div, h1, h2, h3, h4, 
h5, h6, p, ul, ol, li, dl, dt, dd, img, form, fieldset, input, 
textarea, blockquote {margin: 0; padding: 0; border: 0;} body {font: 
15px 'Dosis', sans-serif; text-transform: uppercase; } 
#main_container {position:relative;margin:0px auto;width: 820px;} 
.results{position:relative;background-color: white;margin-
top:40px;margin-left:20px;padding-left:10px;width: 
800px;border:0px;border-top: 1px solid grey;} 
.upper_content_box{position:relative;float:left;background-
color:white;margin-right:10px;margin-
top:0px;height:260px;width:250px;} .results .upper_content_box 
img{width:248px;height:248px;border: 1px solid grey;} 
.lower_content_box{position:relative;background-
color:white;float:left;margin-right:10px;margin-
bottom:10px;height:122px;width:250px;} .results h4{color:red;} 
.results .lower_content_box img{position:relative;float:left;margin-






.results .upper_content_box img:hover {border-color:blue;} .results 
.lower_content_box img:hover {border-color:blue;} a:link { text-
decoration:none; } a:visited { text-decoration:none;  } a:hover { 
text-decoration:none; } a:active { text-decoration:none;  } a:focus 
{ text-decoration:none;  }"; 
         
        try { 
            PrintWriter writer = new 
PrintWriter(pathCSS+"style.css", "UTF-8"); 
            writer.println(cssString); 
            writer.close(); 
        }catch (Exception ex){  
        } 
    } 
    
    public void writeCSV(){ 
        String pathCSV = 
path+os_slash+"pla"+os_slash+"analysis"+os_slash; 
        try { 
            PrintWriter writer = new 
PrintWriter(pathCSV+"ALL_RESULTS.csv", "UTF-8"); 
            String headerString = ""; 
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            for (int k = 0; k<csvHeader.size(); k++){ 
                headerString = headerString + csvHeader.get(k)+";"; 
                } 
            writer.println(headerString); 
            writer.println(allResults); 
 
            writer.close(); 
        }catch (Exception ex){  
        } 
    } 
 
    public void resetAll(){ 
     IJ.run("Close All", ""); 
     IJ.selectWindow("ROI Manager"); 
     IJ.run("Close"); 
        return; 
    } 
} 
 












public class PLA_Dendrites extends ImagePlus implements PlugIn { 
 
 // STRING FOR OS 
 public static String os_system = ""; 
 public static String os_slash = ""; 
 
 public static String version = "0.85"; 
 
 public void run(String arg) { 
  IJ.log("-----------------[ Start PLA_Dendrites 
V"+version+" ]-----------------"); 
 
  os_system = System.getProperty("os.name"); 
     if (os_system.contains("Mac")) 
       os_slash = "/"; 
     else os_slash = "\\"; 
   
  OpenDialog od = new OpenDialog("Select imagefile"); 
  ImagePlus imp = IJ.openImage(od.getPath()); 
 
  String path = 
od.getPath().substring(0,od.getPath().length()-
imp.getTitle().length()); 
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  String imageName = imp.getTitle(); 
  IJ.log("img: "+imageName+" path: "+path); 
   
  // GET MEASUREMENTS (PIXLE/MICRONS) 
  Calibration cal = imp.getCalibration(); 
  double x = cal.pixelWidth; 
  double y = cal.pixelHeight; 
   
  IJ.run(imp, "Select All", ""); 
        Integer oldWidth = (int)imp.getRoi().getFloatWidth(); 
  Integer oldHeight = (int)imp.getRoi().getFloatHeight(); 
        double distance = oldHeight/(oldHeight*x); 
         
        IJ.run(imp, "Select None", ""); 
  IJ.log("Measurements: "+x+" x "+y+" | "+oldWidth+" x 
"+oldHeight+" = "+(oldHeight*x)+" => distance: 
"+oldHeight/(oldHeight*x)); 
   
  IJ.setTool("polyline"); 
  imp.show(); 
  new WaitForUserDialog("Selection required", "1. Track the 
dendrite with left clicks.\n\n2. Place your last selection with 
right click. \n\n3. Press the OK button to continue").show(); 
  IJ.run("Straighten...", 
"title=straightened_"+imp.getTitle()+" line=20"); 
  imp.close(); 
  ImagePlus imp2 = WindowManager.getCurrentImage(); 
  IJ.log("img2: "+imp2.getTitle()); 
   
  String fullpath = createPaths(path); 
  IJ.run(imp2, "Set Scale...", "distance="+distance+" 
known=1 pixel=1 unit=micron"); 
  IJ.saveAs(imp2, "Tiff", 
fullpath+os_slash+imp2.getTitle()); 
  imp2.close(); 
   
  //IJ.run("Close All", ""); 
        System.gc(); 




    public String createPaths(String path){ 
      String fullpath = path+os_slash+"Straightened"+os_slash; 
      Boolean success = (new File(fullpath)).mkdirs(); 
      return fullpath; 




















public class PLA_Soma extends ImagePlus implements PlugIn { 
 
 // STRING FOR OS 
 public static String os_system = ""; 
 public static String os_slash = ""; 
 
 public static String version = "0.85"; 
 
 public void run(String arg) { 
  IJ.log("-----------------[ Start PLA_Soma V"+version+" ]-
----------------"); 
 
  os_system = System.getProperty("os.name"); 
     if (os_system.contains("Mac")) 
       os_slash = "/"; 
     else os_slash = "\\"; 
   
  OpenDialog od = new OpenDialog("Select imagefile"); 
  ImagePlus imp = IJ.openImage(od.getPath()); 
 
  String path = 
od.getPath().substring(0,od.getPath().length()-
imp.getTitle().length()); 
  String imageName = imp.getTitle(); 
  IJ.log("img: "+imageName+" path: "+path); 
 
  // GET MEASUREMENTS (PIXLE/MICRONS) 
  Calibration cal = imp.getCalibration(); 
  double x = cal.pixelWidth; 
  double y = cal.pixelHeight; 
         
        IJ.run(imp, "Select All", ""); 
        Integer oldWidth = (int)imp.getRoi().getFloatWidth(); 
  Integer oldHeight = (int)imp.getRoi().getFloatHeight(); 
        double distance = oldHeight/(oldHeight*x); 
         
        IJ.run(imp, "Select None", ""); 
  IJ.log("Measurements: "+x+" x "+y+" | "+oldWidth+" x 
"+oldHeight+" = "+(oldHeight*x)+" => distance: 
"+oldHeight/(oldHeight*x)); 
   
        // IJ.run(imp, "Set Scale...", "distance=5.5494 known=1 
pixel=1 unit=micron"); 
         
  IJ.setTool("brush"); 
  imp.show(); 
  new WaitForUserDialog("Selection required", "1. Hold the 
left mouse button down and drag the brush over the soma.\n\n2. Areas 
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can be erased by clicking with the brush tool outside the marked 
area and drag it on the zone which shall be removed. \n\n3. Press 
the OK button to continue").show(); 
  IJ.run("Copy", ""); 
 
  Integer newWidth = (int)imp.getRoi().getFloatWidth(); 
  Integer newHeight = (int)imp.getRoi().getFloatHeight(); 
   
  // Add 1/3 of height and width to the borders to make 
sure that the cell mass is less than the background 
  newHeight += 2*(int)(newHeight/3); 
  newWidth  += 2*(int)(newWidth/3); 
   
  Integer bitDepth = imp.getBitDepth(); 
  IJ.log("NewFile: "+newWidth+" x "+newHeight+" bitD: 
"+bitDepth); 
  imp.close(); 
  ImagePlus imp2 = IJ.createImage("brushed_"+imageName, 
bitDepth+"-bit black", newWidth, newHeight, 1); 
  IJ.run(imp2, "Paste", ""); 
  IJ.run(imp2, "Select None", ""); 
  imp2.show(); 
  String fullpath = createPaths(path); 
        IJ.run(imp2, "Set Scale...", "distance="+distance+" known=1 
pixel=1 unit=micron"); 
  IJ.saveAs(imp2, "Tiff", 
fullpath+os_slash+imp2.getTitle()); 
 
  //IJ.run("Close All", ""); 
        System.gc(); 




    public String createPaths(String path){ 
      String fullpath = path+os_slash+"Brushed"+os_slash; 
      Boolean success = (new File(fullpath)).mkdirs(); 
      return fullpath; 
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